<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>v20057exv2w1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;2.1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>DATED AS OF APRIL 26, 2006</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>BY AND AMONG</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIEMENS MEDICAL SOLUTIONS USA, INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>DRESDEN ACQUISITION CORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AND</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>DIAGNOSTIC PRODUCTS CORPORATION</B>
</DIV>



<P align="center" style="font-size: 10pt">
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE I&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DEFINITIONS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE II&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE MERGER</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Merger
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consummation of Merger
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect of Merger
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.4
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Articles of Incorporation and Bylaws
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.5
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Directors and Officers
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.6
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect on the Shares
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.7
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dissenting Shares
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">12</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.8
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exchange of Certificates
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">13</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.9
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stock Options
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">15</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.10
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Closing
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">15</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;2.11
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Adjustments to Merger Consideration
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">16</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">16</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Organization and Qualification
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">16</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authorization
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capitalization and Share Ownership
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.4
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indebtedness
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">18</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.5
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governmental Authorization; Noncontravention
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">19</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.6
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SEC Filings
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">19</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.7
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financial Statements; Undisclosed Liabilities
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">21</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.8
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Absence of Certain Changes
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">22</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.9
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Licenses
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.10
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Litigation; Compliance with Laws
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.11
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employment Matters
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.12
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Matters
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">25</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.13
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Real Property
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">26</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.14
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental Matters
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">28</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.15
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">29</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.16
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intellectual Property
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">29</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.17
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefits
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.18
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Material Contracts
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">34</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.19
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Regulatory Matters.
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">36</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.20
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Affiliate Transaction
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-i-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.21
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Board Recommendation
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.22
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proxy Statement
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">39</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.23
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title to Personal Property
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">39</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.24
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Customers and Suppliers
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">39</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.25
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Products and Services
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">39</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.26
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Business Practices
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">40</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.27
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Financial Advisor
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">40</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;3.28
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Finders and Brokers
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">40</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE IV&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND MERGER SUB</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">40</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Organization and Qualification
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">40</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authorization
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">41</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capitalization and Share Ownership
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">41</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.4
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governmental Authorization; Noncontravention
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">41</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.5
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Litigation
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">42</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.6
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ownership of Company Common Stock
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">42</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.7
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Finder and Brokers
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">42</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;4.8
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Available Funds
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">42</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE V&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PRE-CLOSING COVENANTS AND ADDITIONAL AGREEMENTS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">43</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Conduct of Business
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">43</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preparation of the Proxy Statement; Cooperation on FCPA Matters
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">47</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Access to Information
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">48</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.4
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Shareholders&#146; Meeting
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">49</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.5
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Solicitation
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">49</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.6
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reasonable Best Efforts; Consents
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">51</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.7
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefits
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">52</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.8
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Control of Other Party&#146;s Business
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">53</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.9
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Directors&#146; and Officers&#146; Indemnification and Insurance
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">54</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.10
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Public Statement and Press Releases
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.11
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notice Obligations
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;5.12
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shareholder Claims
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE VI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONDITIONS TO EACH PARTY&#146;S OBLIGATIONS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;6.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Shareholders&#146; Approval
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-ii-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;6.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Legal Prohibition
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;6.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Receipt of Government Consents
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE VII&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONDITIONS TO THE PURCHASER&#146;S AND MERGER SUB&#146;S OBLIGATIONS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;7.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Receipt of Third Party Consents
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;7.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Performance by Company
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;7.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Truth of Representations and Warranties
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;7.4
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company&#146;s Closing Certificate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;7.5
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Material Adverse Effect
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;7.6
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FIRPTA Certificate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE VIII&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONDITIONS TO COMPANY&#146;S OBLIGATIONS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;8.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Performance by the Purchaser and Merger Sub
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;8.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Truth of Representations and Warranties
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;8.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchaser&#146;s Closing Certificate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE IX&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TERMINATION</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">59</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;9.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">59</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;9.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect of Termination
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">60</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;9.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fees and Expenses
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">60</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">ARTICLE X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MISCELLANEOUS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">62</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.1
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendments, Waivers
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">62</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.2
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Entire Agreement
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">62</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.3
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Binding Effect; Assignment
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">62</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.4
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Headings; Certain Construction Rules
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">63</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.5
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notices
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">63</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.6
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governing Law
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.7
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Further Actions
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.8
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gender, Tense, Etc
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.9
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Severability
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.10
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Third Party Rights
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.11
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Survival of Representations and Warranties and Agreements
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.12
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counterparts
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section&nbsp;10.13
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Waiver of Jury Trial
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-iii-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shareholder Agreement</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Agreement of Merger</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-iv-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This AGREEMENT AND PLAN OF MERGER (this &#147;<U>Agreement</U>&#148;), dated as of April&nbsp;26, 2006, is
by and among Siemens Medical Solutions USA, Inc., a Delaware corporation (the &#147;<U>Purchaser</U>&#148;),
Dresden Acquisition Corporation, a California corporation and a wholly-owned subsidiary of the
Purchaser (&#147;<U>Merger Sub</U>&#148;), and Diagnostic Products Corporation, a California corporation
(the &#147;<U>Company</U>&#148; and, together with the Purchaser and Merger Sub, the &#147;<U>Parties</U>&#148; and
each, a &#147;<U>Party</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>RECITALS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the boards of directors of the Purchaser, Merger Sub and the Company each have
unanimously approved this Agreement and have determined that it is in the best interests of their
respective shareholders for Merger Sub to merge with and into the Company, upon the terms and
subject to the conditions of this Agreement, with the Company being the Surviving Corporation (as
defined herein) and becoming a wholly owned subsidiary of the Purchaser (the &#147;<U>Merger</U>&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, in order to induce the Purchaser and Merger Sub to enter into this Agreement, certain
shareholders of the Company, concurrently with the execution of this Agreement, will enter into a
Shareholder Agreement, dated as of the date hereof (the &#147;<U>Shareholder Agreement</U>&#148;), in
substantially the form set forth in <U>Exhibit&nbsp;A</U> hereto; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Purchaser, Merger Sub and the Company desire to make certain representations,
warranties, covenants and agreements in connection with the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the respective representations,
warranties, covenants and agreements set forth herein, and intending to be legally bound hereby,
the Purchaser, Merger Sub and the Company hereby agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE I</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>DEFINITIONS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquisition Proposal</U>&#148; means any of the following (other than the Merger) or any offer
or proposal for any of the following: (i)&nbsp;a merger, consolidation, share exchange, business
combination, reorganization, recapitalization, liquidation, dissolution or other similar
transaction or series of related transactions involving the Company; (ii)&nbsp;any sale, lease,
exchange, transfer or other disposition (including by way of merger, consolidation or exchange), in
a single transaction or a series of related transactions, of the assets of the Company or its
Subsidiaries constituting twenty-five percent (25%) or more of the consolidated assets of the
Company and its Subsidiaries or accounting for twenty-five percent (25%) or more of the
consolidated revenues of the Company and its Subsidiaries; or (iii)&nbsp;any tender offer, exchange
offer or other offer for, or acquisition or other similar transaction or series of related
transactions by any Person or group (within the meaning of Regulation&nbsp;13D under the Exchange Act)
that, if consummated, would result in such Person or group becoming the beneficial owner of,
twenty-five percent (25%) or more of the outstanding Company Common Stock.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Action</U>&#148; means any action, complaint, petition, investigation, suit or other
proceeding, whether administrative, civil or criminal, in law or in equity, by or before any
Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; means, with respect to any specified Person, any other Person that,
directly or indirectly, controls, is controlled by or is under common control with, such specified
Person. For purposes of this definition, &#147;control&#148; (including, with correlative meanings, the
terms &#147;controlled by&#148; and &#147;under common control with&#148;), as used with respect to any Person, means
the possession, directly or indirectly, of the power to direct or cause the direction of the
management or policies of such Person, whether through the ownership of voting securities, by
contract or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Aggregate Number</U>&#148; is defined in <U>Section&nbsp;2.11</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Agreement</U>&#148; is defined in the first paragraph of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Agreement of Merger</U>&#148; is defined in <U>Section&nbsp;2.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Benefit Plans</U>&#148; means all employee benefit plans (as defined in Section&nbsp;3(3) of ERISA)
and all bonus, stock option, stock purchase, restricted stock, incentive, deferred compensation,
retiree medical or life insurance, supplemental retirement, severance or other benefit plans,
programs or arrangements, and all employment, retention, change of control, termination, severance
or other Contracts to which the Company or any of its Subsidiaries is a party, with respect to
which the Company or any of its Subsidiaries has any obligation or that are maintained, contributed
to or sponsored by the Company or any of its Subsidiaries for the benefit of any current or former
employee, officer or director of the Company or any of its Subsidiaries; <I>provided</I>, <I>however</I>, that
the term &#147;Benefit Plan&#148; shall not include a Foreign Plan and shall not include a &#147;multiemployer
plan&#148; as defined in Section&nbsp;3(37) of ERISA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Day</U>&#148; means any day other than a Saturday or Sunday or a day on which
national banking institutions in New York, New York or in Los Angeles, California are authorized or
obligated by law or executive order to be closed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>CGCL</U>&#148; means the California General Corporation Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Change in the Company Recommendation</U>&#148; is defined in <U>Section&nbsp;5.5(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>CLIA</U>&#148; means the Clinical Laboratory Improvement Amendments of 1988 or any successor
statutes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing</U>&#148; is defined in <U>Section&nbsp;2.10</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Date</U>&#148; is defined in <U>Section&nbsp;2.10</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and as the context
requires, the Treasury regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company</U>&#148; is defined in the first paragraph of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Board Recommendation</U>&#148; is defined in <U>Section&nbsp;3.21</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Certificate</U>&#148; is defined in <U>Section&nbsp;2.6(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Common Stock</U>&#148; means the common stock, no par value, of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Disclosure Schedule</U>&#148; is defined in the first paragraph of <U>Article
III</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Intellectual Property</U>&#148; means all Owned Intellectual Property, Third Party
Intellectual Property and all other Intellectual Property necessary for or otherwise material to
the operation of the business of the Company and its Subsidiaries as presently conducted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company IT Systems</U>&#148; means computer systems, networks, hardware, software, databases,
Internet web sites and equipment used to process, store, maintain and operate data, information and
functions used in connection with the operation of the Company and its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Option Plans</U>&#148; means the Diagnostic Products Corporation 1990 Stock Option
Plan, as amended and restated, and the Diagnostic Products Corporation 1997 Stock Option Plan, as
amended and restated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company SEC Reports</U>&#148; is defined in <U>Section&nbsp;3.6(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Shareholders&#146; Approval</U>&#148; means the approval of the Merger and this Agreement
by the holders of a majority of the outstanding shares of Company Common Stock entitled to vote
thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Shareholders&#146; Meeting</U>&#148; is defined in <U>Section&nbsp;5.4</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Stock Options</U>&#148; is defined in <U>Section&nbsp;2.9</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Confidentiality Agreement</U>&#148; means the Confidentiality Agreement dated March&nbsp;6, 2006
between the Company and the Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contract</U>&#148; means any note, bond, mortgage, indenture, deed of trust, loan, credit
agreement, lease, license, purchase order, sales order contract, agreement or other binding
instrument or understanding, whether written or oral.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contracts with the U.S. Government</U>&#148; means any Contract (including a subcontract)
between the Company or any of its Subsidiaries and a U.S. Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Dissenting Shares</U>&#148; is defined in <U>Section&nbsp;2.7</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>D&#038;O Insurance</U>&#148; is defined in <U>Section&nbsp;5.9(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Effective Time</U>&#148; is defined in <U>Section&nbsp;2.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Employee</U>&#148; means any director or employee of the Company or its Subsidiaries.
</DIV>

<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>End Date</U>&#148; is defined in <U>Section&nbsp;9.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Claim</U>&#148; means any written allegation, notice, claim, demand, Action,
request for information or other communication from any Governmental Authority or any Person (other
than the Company or a Subsidiary of the Company) against the Company or a Subsidiary of the Company
in either case alleging noncompliance with or liability or potential liability (including liability
or potential liability or investigatory costs, cleanup costs, governmental response costs, natural
resource damages, property damage, personal injury, fines or penalties) under Environmental Laws,
including the presence, discharge, emission, release or threatened release of any Hazardous
Materials at or from any location that is or has been owned, leased or operated by the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Laws</U>&#148; means any and all applicable U.S. and non-U.S. federal, state and
local laws, statutes, rules, regulations, ordinances, orders, decrees and other laws relating to
the protection of the environment, natural resources, and health and safety as it relates to
environmental protection including contamination, laws relating to Releases of Hazardous Material
into the environment and all laws and regulations with regard to disclosure and reporting
requirements respecting Hazardous Materials and the environment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Permits</U>&#148; means all permits, licenses, registrations and other
governmental authorizations required under Environmental Laws for the Company and its Subsidiaries
to conduct their operations and businesses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA</U>&#148; means the Employee Retirement Security Act of 1974, as amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA Affiliate</U>&#148; means any Person, trade or business, whether or not incorporated,
which together with the Company or any of its Subsidiaries would be considered a &#147;single employer&#148;
within the meaning of Section&nbsp;4001(B) of ERISA or Section&nbsp;414 of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended, together with
the rules and regulations of the SEC promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Agent</U>&#148; is defined in <U>Section&nbsp;2.8(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Fund</U>&#148; is defined in <U>Section&nbsp;2.8(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Excluded Shares</U>&#148; is defined in <U>Section&nbsp;2.6(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>FCPA</U>&#148; is defined in <U>Section&nbsp;3.26</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>FDA</U>&#148; means the United States Food and Drug Administration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>FDC Act</U>&#148; means the Federal Food, Drug and Cosmetic Act and the rules and regulations
promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Foreign Plan</U>&#148; means any employment or consulting agreement, or any plan, program,
arrangement, agreement or commitment sponsored or contributed to by the Company or any of its
Subsidiaries that is not subject to the requirements of ERISA and provides any of the
</DIV>

<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">following benefits to any Employee who does not (or at the time such benefits were provided,
did not) reside in the United States: pension, retirement, savings, termination, retention, change
in control, disability, medical, dental, accident, health or life insurance or other death
benefits, retiree medical or life insurance, supplemental medical, profit sharing, stock option,
stock purchase, restricted stock or other equity-based benefits, bonus or other incentive
compensation, deferred compensation, severance, or other welfare or retirement benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>GAAP</U>&#148; means generally accepted accounting principles as in effect from time to time
in the United States.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>German Regulation</U>&#148; is defined in <U>Section&nbsp;3.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Authority</U>&#148; means any federal, state, local or foreign government or any
agency, authority, subdivision or instrumentality of any of the foregoing, including any court,
tribunal, department, bureau, commission or board.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hazardous Materials</U>&#148; means any element, compound, substance or other material
(including any pollutant, contaminant, hazardous waste, hazardous substance, chemical substance or
product that is listed, classified or regulated pursuant to any Environmental Law, including any
petroleum product, by-product or additive, asbestos, presumed asbestos-containing material,
asbestos-containing material, medical waste, biological waste, chloroflourocarbon,
hydrochloroflourocarbon, lead-containing paint or plumbing, polychlorinated biphenyls (PCBs),
radioactive material, infectious materials, potentially infectious materials or disinfecting
agents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended
from time to time, and the rules and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indebtedness</U>&#148; means (i)&nbsp;indebtedness for borrowed money, whether secured or
unsecured, including indebtedness evidenced by a note, bond, debenture or similar instrument, (ii)
any obligations to pay rent or other amounts under any lease of real or personal property, or a
combination thereof, which obligations are required to be classified and accounted for as capital
leases on a balance sheet under GAAP, but excluding leases of capital equipment entered into in the
ordinary course of business not deemed material under GAAP in the Company&#146;s financial statements,
in each case consistent with past practice, (iii)&nbsp;obligations in respect of outstanding letters of
credit, acceptances and similar obligations, (iv)&nbsp;net obligations under any swap contract or
similar derivative contract, (v)&nbsp;any obligations under conditional or installment sale or other
title retention agreement relating to purchased property or services, or (vi)&nbsp;any direct or
indirect guarantee of another Person in respect of any of the foregoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnified Parties</U>&#148; is defined in <U>Section&nbsp;5.9(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intellectual Property</U>&#148; means all (i)&nbsp;Inventions, (ii)&nbsp;Trademarks, (iii)&nbsp;ownership
rights to any copyrightable works, including registrations and applications for registration
thereof, (iv)&nbsp;Software and (v)&nbsp;confidential and proprietary information, including trade secrets,
know-how, technology, processes, products and methods, whether or not reduced to practice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Inventions</U>&#148; means patents, patent applications, statutory invention
registrations, inventions or discoveries made, developed, conceived or reduced to practice prior to
the
</DIV>


<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Effective Time, including any provisional, utility, continuation, continuation-in-part or
divisional applications filed in the United States or other jurisdiction prior to the Effective
Time, and all reissues thereof and all reexamination certificates issuing therefrom.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>IRS</U>&#148; means the Internal Revenue Service.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Knowledge</U>&#148; means with respect to the Company and any of its Subsidiaries, the actual
knowledge of the individuals listed in <U>Section&nbsp;K of the Company Disclosure Schedule</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Larger Customers</U>&#148; is defined in Section&nbsp;3.24.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Leased Real Property</U>&#148; is defined in <U>Section&nbsp;3.13(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Legal Prohibition</U>&#148; is defined in <U>Section&nbsp;9.1(b)(ii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Legal Requirement</U>&#148; means any statute, ordinance, code, law, rule, regulation, order
or other requirement, standard or procedure enacted, adopted or applied by any Governmental
Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Licenses</U>&#148; is defined in <U>Section&nbsp;3.9</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Liens</U>&#148; means, with respect to any property or asset, any mortgage, easement, lien,
pledge, security interest or other encumbrance of any nature whatsoever in respect of such property
or asset.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Adverse Effect</U>&#148; means
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;any event, change, effect or circumstance that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) has a material adverse effect on the assets, liabilities, business,
properties, results of operations or financial or other condition of the Company and
its Subsidiaries, taken as a whole; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) materially impairs the validity or enforceability of this Agreement
against the Company or materially adversely affects or delays the Company&#146;s ability
to consummate the transactions contemplated hereby or perform its obligations
hereunder; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;(x)&nbsp;a violation by the Company or any of its Subsidiaries on or after the date of
this Agreement of any applicable anti-bribery or other similar requirement of the FCPA or
any similar U.S. federal or state Legal Requirement (any of the foregoing, an
&#147;<U>Anti-Bribery Requirement</U>&#148;), (y)&nbsp;a determination by, or notification to, the Company
or any of its Subsidiaries or Affiliates that any of them has violated any Anti-Bribery
Requirement prior to the date of this Agreement other than the violations (and the disclosed
facts giving rise thereto) identified in <U>Section&nbsp;M of the Company Disclosure
Schedule</U> or (z)&nbsp;an allegation by any Governmental Authority that any of the foregoing
has occurred, or the commencement by any Governmental Authority of any investigation
</DIV>

<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">or proceeding regarding compliance with any Anti-Bribery Requirement (including any
provisions of the settlement agreements (the &#147;<U>Settlement Agreements</U>&#148;) identified in
<U>Section&nbsp;M of the Company Disclosure Schedule</U>); in each case unless the Purchaser
after considering the matter in good faith concludes that the occurrences described in
clauses (x), (y)&nbsp;and (z), individually or in the aggregate, are not likely to (i)&nbsp;impair,
burden or interfere with, or otherwise adversely affect, the conduct of the business of the
Company or any of its Subsidiaries or of the Purchaser or any of its Affiliates after the
Effective Time, (ii)&nbsp;result in the modification or termination of either of the Settlement
Agreements, (iii)&nbsp;result in the initiation of proceedings that may result in civil or
criminal liability of the Company or any of its Subsidiaries or of the Purchaser or any of
its Affiliates after the Effective Time, (iv)&nbsp;result in any material modification of the
scope or character of monitoring required under the Settlement Agreements of the Company&#146;s
(or any of its Affiliates&#146; respective) compliance programs in effect as of the date hereof,
or (v)&nbsp;result in any additional compliance programs being imposed upon the Company, the
Purchaser or any of their respective affiliates, or in any modification of any their
respective compliance programs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Notwithstanding the foregoing, with respect to clause (a)(i) above, the term &#147;Material
Adverse Effect&#148; shall not include any event, change, effect or circumstance arising from:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;general economic, market or political conditions or changes
generally applicable to the industries and markets in which the Company
operates which conditions or changes do not have a materially
disproportionate effect on the Company and its Subsidiaries, taken as a
whole, relative to others in its industry;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;changes generally applicable to the financial or securities
markets;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)&nbsp;any change in GAAP or applicable Legal Requirements after the date
hereof; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)&nbsp;the announcement of the execution of this Agreement or the
prospective consummation of the transactions contemplated by this Agreement
or actions permitted by <U>Section&nbsp;5.5</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Contracts</U>&#148; is defined in <U>Section&nbsp;3.18</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Lease</U>&#148; means any lease or sublease for real property in the United States in
excess of 10,000 square feet in size by the Company or any of its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Maximum Premium Amount</U>&#148; is defined in <U>Section&nbsp;5.9(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger</U>&#148; is defined in the <U>Recitals</U> to this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger Consideration</U>&#148; is defined in <U>Section&nbsp;2.6(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger Sub</U>&#148; is defined in the first paragraph of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Notice of Superior Proposal</U>&#148; is defined in <U>Section&nbsp;5.5(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>NYSE</U>&#148; means the New York Stock Exchange.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option Consideration</U>&#148; is defined in <U>Section&nbsp;2.9</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Owned Intellectual Property</U>&#148; means all Intellectual Property owned by the Company
and/or its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Owned Real Property</U>&#148; is defined in <U>Section&nbsp;3.13(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parties</U>&#148; is defined in the first paragraph of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Party</U>&#148; is defined in the first paragraph of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permitted Liens</U>&#148; means (i)&nbsp;zoning restrictions, easements, rights-of-way or other
restrictions on the use of real property (that do not individually or in the aggregate, materially
interfere with the use of such real property or the Company&#146;s or its Subsidiaries&#146; operation of
their respective business as currently operated), (ii)&nbsp;pledges or deposits by the Company or any of
its Subsidiaries under workers compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids, tenders, contracts or leases to which
such entity is a party, or deposits to secure public or statutory obligations of such entity or
deposits or cash or U.S. government bonds to secure surety or appeal bonds to which such entity is
a party, or deposits as security for contested Taxes or for the payment of rent, in each case
incurred or made in the ordinary course of business, (iii)&nbsp;Liens imposed by Legal Requirement,
including carriers&#146;, warehousemen&#146;s, landlords&#146; and mechanics&#146; liens, in each case incurred in the
ordinary course of business, (iv)&nbsp;Liens for Taxes, assessments or other governmental charges not
yet due and payable, (v)&nbsp;Liens in favor of issuers of surety or performance bonds or letters of
credit or bankers&#146; acceptances issued pursuant to the request of and for the account of the Company
or any of its Subsidiaries in the ordinary course of its business, (vi)&nbsp;Liens from the existing
Indebtedness of the Company or its Subsidiaries, in each case as security for such Indebtedness,
(vii)&nbsp;Liens described in <U>Section&nbsp;L of the Company Disclosure Schedule</U> and (viii)&nbsp;Liens that
have not had and reasonably would not be expected to have, individually or in the aggregate, a
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Person</U>&#148; means a natural person, corporation, partnership, limited partnership,
limited liability company, trust or unincorporated organization or similar entity, or a
Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>PHS Act</U>&#148; means the United States Public Health Service Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Proxy Statement</U>&#148; means the proxy statement to be distributed to the shareholders of
the Company in connection with the Merger and the related transactions contemplated by this
Agreement, including any preliminary proxy statement, definitive proxy statement or supplement or
amendment thereto, in each case as filed with the SEC in accordance with applicable Legal
Requirements and the terms and provisions of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser</U>&#148; is defined in the first paragraph of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Real Property</U>&#148; is defined in <U>Section&nbsp;3.13(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Release</U>&#148; means any release, spill, emission, discharge, leaking, pumping, injection,
deposit, disposal, discharge, dispersal, leaching or migration into or through the indoor or
outdoor environment (including ambient air, surface water, groundwater and surface or subsurface
strata) or into or out of any property, including the movement of Hazardous Materials through or in
the air, soil, surface water, groundwater or property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Representatives</U>&#148; is defined in <U>Section&nbsp;5.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SEC</U>&#148; means the United States Securities and Exchange Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, together with the rules
and regulations of the SEC promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Shareholder Agreement</U>&#148; is defined in the <U>Recitals</U> to this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Software</U>&#148; means computer and electronic data processing software and programs in any
form, including source code, object code, encryption keys and other security features, all
versions, conversions, updates, patches, corrections, enhancements and modifications thereof and
all related documentation, and all formulae and algorithms, used in the ownership, marketing,
development, maintenance, support and delivery of such software thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Special Inventor</U>&#148; means each of the individuals identified in <U>Section&nbsp;SI of the
Company Disclosure Schedule</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SOX</U>&#148; means the Sarbanes-Oxley Act of 2002.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiary</U>&#148; means with respect to any Person, another Person (i)&nbsp;of which greater
than fifty percent (50%) of the capital stock, voting securities, or other ownership or equity
interests having voting power under ordinary circumstances to elect directors or similar members of
the governing body of such Person (or, if there are no such voting interests, greater than fifty
percent (50%) of the equity interests) are owned or controlled, directly or indirectly, by such
first Person or (ii)&nbsp;of which such first Person is a general partner or similar controlling member.
Medical Systems S.p.A., a limited share company organized and existing under the laws of Italy,
shall be deemed a Subsidiary for purposes of <U>Article&nbsp;III</U> only (excluding <U>Section
3.12</U> &#091;Taxes&#093;, 3.13 &#091;Real Property&#093;, <U>3.17</U> &#091;Employee Benefits&#093; and 3.18 &#091;Material
Contracts&#093;(other than with respect to the Material Contracts identified with respect to Medical
Systems S.p.A. set forth in <U>Section&nbsp;3.18(a)</U> of the <U>Company Disclosure Schedule</U>)).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Superior Proposal</U>&#148; is defined in <U>Section&nbsp;5.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Surviving Corporation</U>&#148; is defined in <U>Section&nbsp;2.1</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means (A)&nbsp;all federal, state, local, or foreign taxes of any
kind whatsoever imposed by any Governmental Authority, including, without limitation, income, gross
receipts, license, payroll, employment, unemployment, excise, occupation, windfall profits, customs
duties, capital stock, franchise, profits, withholding, real property, personal property,
</DIV>

<P align="center" style="font-size: 10pt">9
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">sales, use, transfer, value added, alternative or add-on minimum, social security, or
disability taxes, including any interest, additions or penalties with respect thereto, (B)&nbsp;any
liability for the payment of Tax as a result of membership in any consolidated, affiliated,
combined or unitary group of corporations with respect to which the Company or any of its
Subsidiaries is or has been a member on or prior to the Effective Time and (C)&nbsp;any transferee or
secondary liability in respect of any Tax (whether imposed by Legal Requirement or contractual
arrangement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Return</U>&#148; means any return, report, information return or other document (including
any related or supporting information, any Schedule or attachment thereto, and any amendment
thereof) filed or required to be filed with any federal, foreign, state, county or local
Governmental Authority in connection with the determination, assessment, collection, administration
or imposition of any Taxes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Termination Date</U>&#148; is defined in <U>Section&nbsp;9.1</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Termination Fee</U>&#148; is defined in <U>Section&nbsp;9.3(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party</U>&#148; is defined in <U>Section&nbsp;5.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party Intellectual Property</U>&#148; means all Intellectual Property, other than Owned
Intellectual Property, that is used or held for use by the Company and/or a Subsidiary of the
Company, but excluding Software that is used or held for use pursuant to an &#147;off the shelf&#148;
license, has a cost in any twelve (12)&nbsp;month period not exceeding $100,000 and is readily available
through regular commercial distribution channels.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party Intellectual Property Agreement</U>&#148; means any license, sublicense, or other
agreement pursuant to which the Company or any of its Subsidiaries is granted, obtains or holds any
rights to practice or use any Third Party Intellectual Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Trademarks</U>&#148; means names and marks, including product names and marks previously
acquired by the Company or any of its Subsidiaries, brands and slogans, registered and unregistered
trademarks, service marks, domain name registrations, trade dress, logos, and other source
identifiers, including registrations and applications for registration thereof and all goodwill
associated therewith.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>USDA</U>&#148; means the United States Department of Agriculture.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>WARN</U>&#148; means the Workers Adjustment and Retraining Notification Act.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE II</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>THE MERGER</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.1 </B><U><B>The Merger.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the terms and subject to the conditions of this Agreement, and in accordance with the
CGCL, Merger Sub shall be merged with and into the Company at the Effective Time. Following the
Merger, the separate corporate existence of Merger Sub shall cease and the
</DIV>

<P align="center" style="font-size: 10pt">10
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company shall continue as the surviving corporation (the &#147;<U>Surviving Corporation</U>&#148;) in
accordance with the CGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.2 </B><U><B>Consummation of Merger.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At or as soon as practicable after the Closing, the Parties shall cause the Merger to be
consummated by duly filing with the Secretary of State of California an agreement of merger or
other appropriate documents, in substantially the form of <U>Exhibit&nbsp;B</U> (the &#147;<U>Agreement of
Merger</U>&#148;) executed in accordance with the provisions of the CGCL, and shall make all other
filings, recordings or publications required under the CGCL in connection with the Merger. In
accordance with the CGCL and the terms of the Agreement of Merger, the Merger shall be effective at
the time and date of the filing of the Agreement of Merger with the Secretary of State of
California or such other time and date as the Purchaser and the Company may agree and as shall be
specified in the Agreement of Merger (such time being hereinafter referred to as the &#147;<U>Effective
Time</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.3 </B><U><B>Effect of Merger.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Merger shall have the effects set forth in this <U>Article&nbsp;II</U> and in Section&nbsp;1107 of
the CGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.4 </B><U><B>Articles of Incorporation and Bylaws.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The articles of incorporation of Merger Sub, as in existence immediately prior to the
Effective Time, shall be the articles of incorporation of the Surviving Corporation from and after
the Effective Time unless and until amended in accordance with their terms and as provided by
applicable Legal Requirements. The bylaws of Merger Sub, as in effect immediately prior to the
Effective Time, shall be the bylaws of the Surviving Corporation from and after the Effective Time
unless and until amended in accordance with their terms and the terms of the articles of
incorporation of the Surviving Corporation and as provided by applicable Legal Requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.5 </B><U><B>Directors and Officers.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the Purchaser in its sole and absolute discretion, from and
after the Effective Time, the directors and officers identified in <U>Section&nbsp;2.5 of the Company
Disclosure Schedule</U> shall be the initial directors and officers of the Surviving Corporation.
Such persons shall serve as directors or hold office in accordance with the articles of
incorporation and bylaws of the Surviving Corporation until the earlier of their resignation or
removal or until their respective successors are duly elected or appointed and qualified.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.6 </B><U><B>Effect on the Shares.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the Effective Time, by virtue of the Merger and without any action on the part of the
Purchaser, Merger Sub, the Company or the holder of any shares of Company Common Stock or any
shares of common stock of Merger Sub, the following shall occur:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>Cancellation and Conversion of Certain Stock</I>. Each share of Company Common Stock that
immediately prior to the Effective Time is held by the Company or any of
</DIV>

<P align="center" style="font-size: 10pt">11
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">its wholly-owned Subsidiaries (other than shares held either in a fiduciary or agency capacity
that are beneficially owned by third parties or in satisfaction of prior debts), or by the
Purchaser or any of its wholly-owned Subsidiaries (other than shares held either in a fiduciary or
agency capacity that are beneficially owned by third parties or in satisfaction of prior debts)
(collectively, the &#147;<U>Excluded Shares</U>&#148;) shall automatically be canceled and retired and shall
cease to exist and no cash or other consideration shall be delivered in exchange therefor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Conversion of Common Stock</I>. Subject to <U>Section&nbsp;2.7</U>, each share of Company Common
Stock issued and outstanding immediately prior to the Effective Time (other than Dissenting Shares
and Excluded Shares) shall be converted into the right to receive $58.50 in cash payable to the
holder thereof, without interest (the &#147;<U>Merger Consideration</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<I>Cancellation and Retirement of the Company Common Stock</I>. All issued and outstanding
shares of Company Common Stock (other than Dissenting Shares, which shall be treated in accordance
with <U>Section&nbsp;2.7</U>, and Excluded Shares, which shall be canceled in accordance with
<U>Section&nbsp;2.6(a)</U>) shall no longer be outstanding and shall automatically be canceled and
retired and shall cease to exist, and each holder of a certificate (each a &#147;<U>Company
Certificate</U>&#148;) previously representing any such shares of Company Common Stock shall cease to
have any rights with respect thereto, except the right to receive, upon surrender of such Company
Certificate in accordance with <U>Section&nbsp;2.8</U>, the Merger Consideration into which the shares
of Company Common Stock represented by such Company Certificate have been converted pursuant to
this <U>Section&nbsp;2.6</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<I>Conversion of Stock of Merger Sub</I>. Each share of common stock, par value $0.01 per share,
of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted
into one share of common stock, no par value per share, of the Surviving Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.7 </B><U><B>Dissenting Shares.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provision of this Agreement to the contrary, shares of Company Common
Stock that are issued and outstanding immediately prior to the Effective Time and that are or may
become &#147;dissenting shares&#148; within the meaning of Section&nbsp;1300(B) of the CGCL (the &#147;<U>Dissenting
Shares</U>&#148;) shall not be converted into or otherwise represent the right to receive the Merger
Consideration in accordance with <U>Section&nbsp;2.6(c)</U>, but shall represent and become the right
to receive such consideration as may be determined to be due such holder under Chapter&nbsp;13 of the
CGCL. If, after the Effective Time, any such holder fails to perfect or withdraws or otherwise
loses its right to dissent, such holder&#146;s shares shall be treated as if they had been converted as
of the Effective Time into the right to receive, upon surrender as provided above, the Merger
Consideration, without any interest, in accordance with <U>Section&nbsp;2.6(c)</U>. The Company shall
give the Purchaser prompt notice of any demands received by the Company for appraisal of shares,
and the Purchaser shall have the right to participate in all negotiations and proceedings with
respect to such demands. Except with the prior written consent of the Purchaser or as may
otherwise be required by applicable Legal Requirements, the Company shall not make any payment with
respect to, or settle or offer to settle, any such demands.
</DIV>

<P align="center" style="font-size: 10pt">12
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.8 </B><U><B>Exchange of Certificates.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>Exchange Agent</I>. Prior to the Closing Date, the Purchaser shall appoint a bank or trust
company (reasonably acceptable to the Company) to act as exchange agent (the &#147;<U>Exchange
Agent</U>&#148;) for the payment of the Merger Consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Exchange Fund</I>. Upon the Effective Time and from time to time thereafter, the Purchaser
shall make available to the Exchange Agent cash in amounts necessary to pay the Merger
Consideration (the &#147;<U>Exchange Fund</U>&#148;) due upon the surrender of the Company Certificates.
Other than investments permitted by <U>Section&nbsp;2.8(i)</U> &#091;Investment of Exchange Fund&#093;, the
Exchange Fund shall not be used for any purpose other than the payment of the Merger Consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<I>Exchange Procedures</I>. Promptly after the Effective Time, the Purchaser shall, or shall
cause the Surviving Corporation to, cause the Exchange Agent to send to each holder of record of
the Company Certificates whose shares were converted pursuant to <U>Section&nbsp;2.6 </U>into the right
to receive the Merger Consideration (i)&nbsp;a letter of transmittal (which shall specify that delivery
shall be effected, and risk of loss and title to the Company Certificates shall pass, only upon
delivery of the Company Certificates to the Exchange Agent and shall be in such form and have such
other provisions as the Purchaser shall reasonably specify) and (ii)&nbsp;instructions for use in
effecting the surrender of the Company Certificates in exchange for the Merger Consideration. Upon
surrender of a Company Certificate for cancellation to the Exchange Agent, together with such
letter of transmittal, duly executed and completed in accordance with the instructions thereto, and
such other documents as may reasonably be required by the Exchange Agent, the holder of such
Company Certificate shall be entitled to receive in exchange payment in the amount of the Merger
Consideration (less any required Tax withholding) that the holder is entitled to receive under
<U>Section&nbsp;2.6</U>, and the Company Certificate so surrendered shall immediately be canceled. No
interest will be paid or accrued with respect to any Merger Consideration deliverable upon due
surrender of the Company Certificates. In the event of a transfer of ownership of the Company
Common Stock that is not registered in the transfer records of the Company, payment may be made to
a transferee if, and only if, the Company Certificate representing such Company Common Stock is
presented to the Exchange Agent, accompanied by all documents required to evidence and effect such
transfer and by evidence that any applicable stock transfer taxes have been paid. Until
surrendered as contemplated by this <U>Section&nbsp;2.8</U>, each Company Certificate (other than the
Company Certificates representing Dissenting Shares) shall be deemed at any time after the
Effective Time for all purposes to represent only the right to receive upon such surrender the
Merger Consideration which the holder thereof has the right to receive in respect of such Company
Certificate pursuant to this <U>Article&nbsp;II</U>. In the case of the Company Certificates
representing Dissenting Shares, each Company Certificate representing Dissenting Shares shall be
deemed at any time after the Effective Time for all purposes to represent only the right to receive
the fair value of such Dissenting Shares pursuant to the CGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<I>No Further Ownership Rights in the Company Common Stock; Transfer Books</I>. The payment of
the Merger Consideration upon the surrender for exchange of shares of Company Common Stock in
accordance with the terms hereof shall be deemed to have been issued and made in full satisfaction
of all rights pertaining to such shares of the Company
</DIV>

<P align="center" style="font-size: 10pt">13
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Common Stock as of the Effective Time, and (except with respect to Dissenting Shares)
following the Effective Time, there shall be no further registration of transfers on the stock
transfer books of the Surviving Corporation of the shares of the Company Common Stock that were
outstanding immediately prior to the Effective Time. If, after the Effective Time, the Company
Certificates are presented to the Surviving Corporation for any reason, they shall be canceled and
exchanged as provided in this <U>Section&nbsp;2.8</U>, subject to applicable Legal Requirements in the
case of the Company Certificates representing Dissenting Shares. From and after the Effective
Time, holders of the Company Certificates shall cease to have any rights as shareholders of the
Company, except as provided by Legal Requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<I>Lost, Stolen or Destroyed Certificates</I>. If any Company Certificates shall have been lost,
stolen or destroyed, then payment shall be made in accordance with this <U>Section&nbsp;2.8</U> in
exchange for such lost, stolen or destroyed Company Certificates, upon the delivery to the Exchange
Agent of an affidavit of that fact by the Person claiming such Company Certificate to be lost,
stolen or destroyed and an indemnity in form reasonably satisfactory to the Purchaser (and, if
required by the Purchaser, the posting by such Person of a bond, in such reasonable amount as the
Purchaser may direct, to support such indemnity) against any claim that may be made against the
Exchange Agent or the Purchaser or otherwise with respect to such Company Certificate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<I>Transferred Certificates</I>. If any payment under this <U>Section&nbsp;2.8</U> is to be made to
a Person other than the Person in whose name the Company Certificate surrendered in exchange
therefor is registered, it shall be a condition of payment that the Company Certificate so
surrendered shall be properly endorsed or otherwise in proper form for transfer and that the Person
requesting such payment shall pay any transfer or other Taxes required by reason of the payment to
a person other than the registered holder of the Company Certificate surrendered or such Person
shall establish to the satisfaction of the Surviving Corporation that such Tax has been paid or is
not applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<I>Termination of Exchange Fund</I>. Any portion of the Exchange Fund made available to the
Exchange Agent pursuant to this <U>Section&nbsp;2.8</U> that remains undistributed to holders of the
Company Certificates for one (1)&nbsp;year after the Effective Time, together with all interest and
other income received by the Exchange Agent with respect thereto, shall be delivered by the
Exchange Agent to the Purchaser and any holders of the Company Certificates who have not
theretofore complied with this <U>Section&nbsp;2.8</U> shall thereafter only look to the Surviving
Corporation (subject to abandoned property, escheat and other similar Legal Requirements), only as
general creditors thereof, with respect to any Merger Consideration that may be payable upon due
surrender of the Company Certificates held by them.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<I>No Liability</I>. Neither the Purchaser, the Company, the Surviving Corporation nor the
Exchange Agent shall be liable to any former holder of shares of the Company Common Stock for any
stock or cash held by the Purchaser, the Surviving Corporation or the Exchange Agent for payment
pursuant to this <U>Section&nbsp;2.8</U> properly delivered to a public official pursuant to any
applicable abandoned property, escheat or similar Legal Requirement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<I>Investment of Exchange Fund</I>. The Exchange Agent shall invest the Exchange Fund as
directed by the Purchaser; <I>provided </I>that such investment shall be in (i)
</DIV>

<P align="center" style="font-size: 10pt">14
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">securities issued or directly and fully guaranteed or insured by the United States of America
government or any agency or instrumentality thereof, (ii)&nbsp;commercial paper obligations rated A-1 or
P-1 or better by Moody&#146;s Investor Services, Inc. or Standard &#038; Poor&#146;s Corporation, respectively, or
(iii)&nbsp;certificates of deposit and bankers&#146; acceptances and overnight bank deposits with any
commercial bank, depository institution or trust company incorporated or doing business under the
laws of the United States of America, any state thereof or the District of Columbia. Any interest
and other income resulting from such investments shall be the property of, and paid to, the
Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<I>Withholding Rights</I>. The Purchaser, the Surviving Corporation and the Exchange Agent shall
be entitled to deduct and withhold from the Merger Consideration otherwise payable to any holder of
Company Certificates pursuant to this <U>Section&nbsp;2.8</U> such amounts as may be required to be
deducted and withheld with respect to the making of such payment under the Code or under any
applicable Legal Requirement. To the extent that amounts are so withheld by the Purchaser, the
Surviving Corporation or the Exchange Agent, such withheld amounts shall be treated for all
purposes of this Agreement as having been paid to the holder of the shares of the Company Common
Stock in respect of which such deduction or withholding was made by the Purchaser, the Surviving
Corporation or the Exchange Agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.9 </B><U><B>Stock Options.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the Effective Time, each holder of an outstanding and unexercised stock option (the
&#147;<U>Company Stock Options</U>&#148;) under the Company Option Plans, whether or not vested or
exercisable, shall be entitled to receive from the Company, an amount in cash (net of any
applicable withholding Taxes) equal to the product of (A)&nbsp;the total number of shares of the Company
Common Stock subject to the Company Stock Option immediately prior to the Effective Time
(regardless of whether then exercisable) and (B)&nbsp;the excess of the Merger Consideration per share
over the exercise price per share of the Company Common Stock subject to the Company Stock Option
immediately prior to the Effective Time (regardless of whether then exercisable) (such amount, the
&#147;<U>Option Consideration</U>&#148;); <I>provided</I>, <I>however</I>, that any Company Stock Option that has an
exercise price per share of the Company Common Stock that is equal to or greater than the Merger
Consideration per share shall be canceled in full without any payment in respect thereof; and
<I>provided, further, </I>that at and after the Effective Time (and subject to the rights of holders to
receive the payment contemplated by this <U>Section&nbsp;2.9</U>), all Company Stock Options shall be
canceled in full (and the Company shall take any and all necessary action to cause such
cancellation to occur at such time), and no Company Stock Options shall be exercisable, whether for
shares of Company Common Stock, shares of the Purchaser common stock or otherwise. The Company
shall pay the Option Consideration to such holders promptly after the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.10 </B><U><B>Closing.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless the transactions herein contemplated have been abandoned and this Agreement terminated
pursuant to <U>Section&nbsp;9.1</U>, the closing of the transactions contemplated by this Agreement
(the &#147;<U>Closing</U>&#148;) shall take place at the offices of O&#146;Melveny &#038; Myers LLP, 400 South Hope
Street, Los Angeles, CA 90071, on the second (2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP>) Business Day after all of the closing
conditions set forth in <U>Article&nbsp;VI</U>, <U>VII</U> and <U>VIII</U> have been satisfied or
waived (except for
</DIV>

<P align="center" style="font-size: 10pt">15
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">those conditions that, by the express terms thereof, are not capable of being satisfied until
the Effective Time, but subject to the satisfaction or waiver of those conditions) or on such other
date as shall be agreed in writing between the Company and the Purchaser. The date on which the
Closing occurs is referred to in this Agreement as the &#147;<U>Closing Date</U>.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;2.11 </B><U><B>Adjustments to Merger Consideration.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Company changes or establishes a record date for changing the number of shares of
Company Common Stock outstanding as a result of a stock split, stock dividend, recapitalization,
subdivision, reclassification, combination or other similar transaction in respect of the
outstanding shares of Company Common Stock and the record date therefor shall be prior to the
Effective Time, then the Merger Consideration shall be proportionately adjusted. If the aggregate
number of outstanding shares of Company Common Stock on a fully diluted basis is greater than the
aggregate number represented in <U>Section&nbsp;3.3</U> to be outstanding plus the amounts permitted to
be issued after the date of this Agreement pursuant to <U>Section&nbsp;5.1</U> (the &#147;<U>Aggregate
Number</U>&#148;), then the Purchaser may adjust the Merger Consideration and Option Consideration
accordingly, but only if and to the extent that such number of additional shares in excess of the
Aggregate Number would cause an adjustment of $0.20 or greater per share in the Merger
Consideration.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE III</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company represents and warrants to the Purchaser and Merger Sub that, except as set forth
in the Company Disclosure Schedule delivered by the Company to the Purchaser prior to the execution
and delivery of this Agreement, which Company Disclosure Schedule identifies exceptions only by the
specific section or subsection of this Agreement to which each entry relates, which exceptions
shall also apply to any other section or subsection of this Agreement to the extent that it is
reasonably apparent that such exceptions are applicable to any other such section or subsection
(the &#147;<U>Company Disclosure Schedule</U>&#148;):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.1 </B><U><B>Organization and Qualification.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company is a corporation duly formed, validly existing and in good standing under the
laws of the State of California and has all requisite corporate powers to own, lease and operate
its properties and to carry on its business as currently conducted. The Company is duly qualified
or licensed to do business as a foreign corporation or other foreign legal entity and is in good
standing in each jurisdiction where such qualification is necessary (except, in the case of good
standing, for entities organized under the laws of any jurisdiction that does not recognize such
concept), with such exceptions as have not had and reasonably would not be expected to have,
individually or in the aggregate, a Material Adverse Effect. The articles of incorporation and
bylaws (or equivalent organizational documents) of the Company and the Subsidiaries are in full
force and effect and neither the Company nor any of its Subsidiaries is in violation of any of
their respective provisions. Complete and correct copies of the articles of incorporation and
bylaws, all as amended to date, of the Company, have been delivered or made available to the
Purchaser.
</DIV>

<P align="center" style="font-size: 10pt">16
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Section&nbsp;3.1(b) of the Company Disclosure Schedule</U> sets forth all Subsidiaries of
the Company. Each Subsidiary of the Company has been formed and is validly existing and in good
standing under the laws of its jurisdiction of incorporation or organization, and has all requisite
corporate or other equivalent powers to own, lease and operate its properties and to carry on its
business as currently conducted. Each Subsidiary of the Company is duly qualified or licensed to
do business as a foreign corporation or other foreign legal entity and is in good standing in each
jurisdiction where such qualification is necessary (except, in the case of good standing, for
entities organized under the laws of any jurisdiction that does not recognize such concept), with
such exceptions as have not had and reasonably would not be expected to have, individually or in
the aggregate, a Material Adverse Effect. The Company does not own, directly or indirectly, any
capital stock or other equity securities or equity interest of any Person, and the Company is not
subject to any obligation or requirement to provide funds to or make any investment (in the form of
a loan, capital contribution or otherwise) in any other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.2 </B><U><B>Authorization.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has all requisite corporate power and corporate authority to execute and deliver
this Agreement, to perform its obligations under this Agreement and, subject to obtaining the
Company Shareholders&#146; Approval with respect to the Merger, to consummate the transactions
contemplated hereby. The execution, delivery and performance by the Company of this Agreement and
the consummation by the Company of the transactions contemplated hereby have been duly authorized
by the Company, and no other corporate proceedings on the part of the Company are necessary to
authorize this Agreement or to consummate the transactions so contemplated (other than, with
respect to the Merger, obtaining the Company Shareholders&#146; Approval). This Agreement has been duly
authorized, executed and delivered by the Company, and constitutes the legally valid and binding
obligation of the Company (assuming due authorization, execution and delivery of this Agreement by
the Purchaser and Merger Sub), enforceable against the Company in accordance with its terms, except
as the same may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent
conveyance, moratorium or similar laws affecting generally the enforcement of creditors&#146; rights and
remedies and general principles of equity, including any limitations on the availability of the
remedy of specific performance or injunctive relief regardless of whether specific performance or
injunctive relief is sought in a proceeding at law or in equity. No California anti-takeover
statute or other similar statute applies to this Agreement, the Shareholder Agreement or the
transactions contemplated hereby and thereby, including the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.3 </B><U><B>Capitalization and Share Ownership.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Agreement, the authorized capital stock of the Company consists of
60,000,000 shares of Company Common Stock. At the close of business on April&nbsp;24, 2006, (A)
29,582,667 shares of Company Common Stock were issued and outstanding, and (B)&nbsp;2,202,122 shares of
Company Common Stock were reserved for issuance pursuant to Company Stock Options. All outstanding
shares of the Company Common Stock are duly authorized, validly issued, fully paid and
nonassessable, and no class of capital stock of the Company is entitled to preemptive (or similar)
rights. All of the shares of the Company Common Stock which may be issued pursuant to the Company
Stock Options will be, when issued, duly authorized, validly issued, fully paid and nonassessable and not subject to
</DIV>

<P align="center" style="font-size: 10pt">17
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">preemptive (or similar) rights. <U>Section </U><U>3.3 of the Company Disclosure Schedule</U> contains a true and complete list, as of April
24, 2006, of all outstanding options, including grant dates, expiration dates, exercise prices,
vesting schedules and the names of the holders thereto, to purchase shares of Company Common Stock
granted under the Company Option Plans. From April&nbsp;24, 2006 until the execution of this Agreement,
the Company has not issued any capital stock or any options, warrants or other rights to acquire
capital stock (or securities convertible into or exercisable or exchangeable for capital stock),
other than the issuance of shares of Company Common Stock pursuant to Company Stock Options that
were outstanding as of the close of business on April&nbsp;24, 2006. Other than as set forth in
<U>Section&nbsp;3.3 of the Company Disclosure Schedule</U>, there are no options, warrants or other
rights to acquire capital stock, or other equity or voting interests in the Company or any of its
Subsidiaries or securities convertible into or exercisable or exchangeable for capital stock or
other equity or voting interests in the Company or any of its Subsidiaries. <U>Section&nbsp;3.1(b) of
the Company Disclosure Schedule</U> sets forth the Company&#146;s (and any other applicable Person&#146;s)
ownership interest in the outstanding shares of capital stock of, or other equity or voting
interest in, each of the Company&#146;s direct and indirect Subsidiaries and, with respect to each such
Subsidiary, the jurisdiction of its organization. Each such share or interest is duly authorized,
validly issued, fully paid and nonassessable and, except as indicated in <U>Section&nbsp;3.1(b) of the
Company Disclosure Schedule</U>, owned by the Company, directly or indirectly, free and clear of
all options, rights of first refusal or similar rights, encumbrances and security interests of any
kind or nature whatsoever and any other Liens, other than Permitted Liens. Except pursuant to
Company Stock Options outstanding as of the date of this Agreement under the Company Option Plans,
there are no outstanding obligations of the Company or any of its Subsidiaries to issue, sell or
transfer, repurchase, redeem or otherwise acquire any shares of capital stock, voting securities,
equity interests or securities convertible into or exchangeable or exercisable for capital stock or
voting securities, warrants, calls or options of the Company or any of its Subsidiaries and, as of
the date hereof, no irrevocable proxies have been granted and, except for the Shareholders
Agreement, no voting agreements to which the Company or a Subsidiary of the Company is a party or,
to the Knowledge of the Company, to which any other Person is a party, exist with respect to the
shares of the Company Common Stock or equity of Subsidiaries of the Company. No shares of the
Company Common Stock are owned by any Subsidiary of the Company. There are no bonds, debentures,
notes or other indebtedness of the Company or Subsidiary of the Company having the right to vote
(or convertible into securities having the right to vote) on any matters on which shareholders of
the Company may vote. Neither the Company nor any of its Subsidiaries has agreed to register any
securities under the Securities Act or under any state securities law or granted registration
rights with respect thereto to any Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.4 </B><U><B>Indebtedness.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;3.4 of the Company Disclosure Schedule</U> sets forth all of the agreements or
instruments pursuant to which any Indebtedness of the Company and its Subsidiaries is outstanding
as of April&nbsp;24, 2006. Other than as set forth in <U>Section&nbsp;3.4 of the Company Disclosure
Schedule</U>, there is no default or event of default under any such agreement or instrument, and
no event has occurred, which, with notice or lapse of time or both, would be a default or event of
default under any such agreement or instrument which would give the other party the right to
accelerate any Indebtedness of the Company or any of its Subsidiaries.
</DIV>

<P align="center" style="font-size: 10pt">18
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.5 </B><U><B>Governmental Authorization; Noncontravention.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The execution, delivery and performance by the Company of this Agreement and the
consummation by the Company of the transactions contemplated hereby requires no consent, approval,
authorization, qualification, order or permit of, action by or in respect of, or filing or
registration with or notification to, any Governmental Authority, other than (i)&nbsp;the filing of the
Agreement of Merger with the Secretary of State of the State of California and appropriate
documents with the relevant authorities of other states in which the Company is qualified to do
business, (ii)&nbsp;compliance with any applicable requirements of the HSR Act and the German Act
Against Restraints on Competition (GWB) (the &#147;<U>German Regulation</U>&#148;), if required, and other
similar filings under the antitrust or anti-competition Legal Requirements of other foreign
countries, (iii)&nbsp;compliance with any applicable requirements of the Securities Act, the Exchange
Act and any other applicable securities Legal Requirements, (iv)&nbsp;such other consents, approvals,
authorizations and notifications as are set forth in <U>Section&nbsp;3.5(a) of the Company Disclosure
Schedule</U>, (v)&nbsp;filings required to be made with the NYSE and (vi)&nbsp;such other items, the absence
of which reasonably would not be expected to have, individually or in the aggregate, a Material
Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The execution, delivery and performance by the Company of this Agreement and the
consummation by the Company of the transactions contemplated hereby do not and will not (i)
contravene, conflict with or result in any violation or breach of any provision of the articles of
incorporation or bylaws of the Company or similar organization documents of any of its
Subsidiaries, (ii)&nbsp;contravene, conflict with or result in a violation or breach of any provision of
any Legal Requirement applicable to the Company or any of its Subsidiaries or by which its or their
respective properties or assets are bound, (iii)&nbsp;require any consent or other action by any Person
(other than as set forth in <U>Section&nbsp;3.5(a)</U>) under, constitute a default (or an event that,
with or without notice or lapse of time or both, would constitute a default), or result in the
creation of any Lien upon any of the properties or assets of the Company or any of its
Subsidiaries, or cause or permit the termination, cancellation, acceleration, triggering or other
change of any right or obligation or the loss of any benefit to which the Company or any Subsidiary
of the Company is entitled under any provision of any Material Contract binding upon the Company or
any Subsidiary of the Company, other than such exceptions in the case of clauses (ii)&nbsp;and (iii)&nbsp;as
reasonably would not be expected to have, individually or in the aggregate, a Material Adverse
Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.6 </B><U><B>SEC Filings.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Since January&nbsp;1, 2004, the Company has filed on a timely basis all reports, prospectuses,
forms, schedules, proxy statements, registration statements and other similar documents required to
be so filed with the SEC (collectively, and to the extent publicly available, the &#147;<U>Company SEC
Reports</U>&#148;). No Subsidiary of the Company is required to file any report, prospectus, form,
schedule, proxy statement, registration statement or other similar documents with the SEC. A true
and complete copy of each of the Company SEC Reports filed prior to the date hereof has been made
available to the Purchaser prior to the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All Company SEC Reports, as of their respective filing dates (and as of the date of any
amendment to the respective Company SEC Reports), complied in all material
</DIV>

<P align="center" style="font-size: 10pt">19
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">respects with the applicable requirements of the Securities Act, the Exchange Act and the
rules and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;None of the Company SEC Reports (including any exhibits and financial statements included
or incorporated by reference therein), as of their respective filing dates (with respect to filings
made under the Exchange Act) or as of the respective dates upon which such filing became effective
(with respect to filings made under the Securities Act), (and, if amended or superseded prior to
the date of this Agreement, then on the date of such filing), contained any untrue statement of a
material fact or omitted to state any material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the principal executive officer of the Company and the principal financial officer
of the Company (or each former principal executive officer of the Company and each former principal
financial officer of the Company, as applicable) has made all certifications required by Rule
13a-14 or 15d-14 under the Exchange Act or Sections&nbsp;302 and 906 of SOX and the rules and
regulations of the SEC promulgated thereunder with respect to the Company SEC Reports, and to the
knowledge of the signatories thereof, the statements contained in such certifications are true and
correct. For purposes of this <U>Section&nbsp;3.6(d)</U>, &#147;principal executive officer&#148; and &#147;principal
financial officer&#148; shall have the meanings given to such terms in SOX. Neither the Company nor any
of its Subsidiaries has outstanding, or has arranged any outstanding, &#147;extensions of credit&#148; to
directors or executive officers within the meaning of Section&nbsp;402 of SOX.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Neither the Company nor any of its Subsidiaries is a party to, or has any commitment to
become a party to, any joint venture, off-balance sheet partnership or any similar contract or
arrangement (including any contract or arrangement relating to any transaction or relationship
between or among the Company and any of its Subsidiaries, on the one hand, and any unconsolidated
Affiliate, including any structured finance, special purpose or limited purpose entity or Person,
on the other hand or any &#147;off-balance sheet arrangements&#148; (as defined in Item&nbsp;303(A) of Regulation
S-K promulgated by the SEC)), where the result, purpose or intended effect of such contract or
arrangement is to avoid disclosure of any material transaction involving, or material liabilities
of, the Company or any of its Subsidiaries in the Company&#146;s or such Subsidiary&#146;s published
financial statements or other of the Company SEC Reports.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company maintains a system of internal controls over financial reporting (as defined
in Rules&nbsp;13a-15(F) and 15d-15(F) under the Exchange Act) sufficient to provide reasonable
assurances regarding the reliability of its financial reporting and preparation of financial
statements for external purposes in accordance with GAAP. The Company&#146;s management has disclosed,
based on its most recent evaluation, to the Company&#146;s outside auditors and the audit committee of
the Company&#146;s board of directors (x)&nbsp;any significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting that are reasonably likely to
adversely affect the Company&#146;s ability to record, process, summarize and report financial data and
(y)&nbsp;any fraud, whether or not material, that involves management or other employees who have a
significant role in the Company&#146;s internal control over financial reporting. A copy of any such
disclosures made by the Company&#146;s management
</DIV>

<P align="center" style="font-size: 10pt">20
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to the Company&#146;s outside auditors and the audit committee have been previously provided to the
Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The Company has in place the &#147;disclosure controls and procedures&#148; (as defined in Rules
13a-15(E) and 15d-15(E) under the Exchange Act) required in order for the Chief Executive Officer
and Chief Financial Officer of the Company to engage in the review and evaluation process mandated
by the Exchange Act and the rules promulgated thereunder. The Company&#146;s &#147;disclosure controls and
procedures&#148; are reasonably designed to ensure that all information (both financial and
non-financial) required to be disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the SEC, and that all such information is accumulated and
communicated to the Company&#146;s management as appropriate to allow timely decisions regarding
required disclosure and to make the certifications of the Chief Executive Officer and Chief
Financial Officer of the Company required under the Exchange Act with respect to such reports.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Since January&nbsp;1, 2004, to the Knowledge of the Company (i)&nbsp;neither the Company nor any of
its Subsidiaries nor any director, officer, employee, auditor, accountant or representative of the
Company or any of its Subsidiaries has received or otherwise had or obtained knowledge of any
material complaint, allegation, assertion or claim, whether written or oral, regarding fraud in the
accounting or auditing practices, procedures, methodologies or methods of the Company or any of its
Subsidiaries or their respective internal accounting controls, including any material complaint,
allegation, assertion or claim that the Company or any of its Subsidiaries has engaged in
inappropriate accounting or auditing practices, and (ii)&nbsp;no attorney representing the Company or
any of its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has
reported evidence of a material violation of securities laws or a violation of federal laws
relating to fraud against shareholders by the Company or any of its officers, directors, employees
or agents to the Company&#146;s board of directors (or any committee thereof) or to any director or
officer of the Company, or to the general counsel or equivalent officer of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.7 </B><U><B>Financial Statements; Undisclosed Liabilities.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>Company Financial Statements. </I>The audited consolidated financial statements and unaudited
consolidated interim financial statements of the Company and its Subsidiaries (including any
related notes and schedules) included in the Company SEC Reports (i)&nbsp;have been prepared in
accordance with past practice and GAAP during the periods involved (except as otherwise stated
therein and subject to normal year-end audit adjustments, not material in amount, in the case of
any unaudited interim financial statements) applied on a consistent basis during the periods
involved and (ii)&nbsp;fairly present in all material respects the consolidated financial position of
the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results
of operations and changes in financial position for the periods or as of the dates then ended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Undisclosed Liabilities</I>. Except as set forth in the Company&#146;s consolidated balance sheet
at December&nbsp;31, 2005 included in the Company&#146;s Form 10-K for the year ended December&nbsp;31, 2005, none
of the Company and its Subsidiaries has any liability or
</DIV>

<P align="center" style="font-size: 10pt">21
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">obligation of any kind whatsoever, whether accrued, contingent, absolute, determined,
determinable or otherwise, other than (i)&nbsp;liabilities or obligations incurred in the ordinary
course of business consistent with past practice since December&nbsp;31, 2005, none of which has had or
reasonably would be expected to have, individually or in the aggregate, a Material Adverse Effect,
(ii)&nbsp;immaterial liabilities or obligations or (iii)&nbsp;liabilities or obligations otherwise set forth
on <U>Section&nbsp;3.7(b) of the Company Disclosure Schedules</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.8 </B><U><B>Absence of Certain Changes.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in the Company SEC Reports that were filed and publicly available prior to
April&nbsp;25, 2006, since December&nbsp;31, 2005, or as otherwise expressly permitted by this Agreement, the
business of the Company and its Subsidiaries has been operated in the ordinary course and
consistent with past practice and since such date there has not occurred:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;any Material Adverse Effect or any event, change, effect or circumstance that reasonably
would be expected to have, individually or in the aggregate, a Material Adverse Effect;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;any declaration, payment or setting aside for payment of any dividend (other than the
Company&#146;s regular quarterly dividend, which shall not be in excess of $0.07 per share) or other
distribution by the Company or any of its Subsidiaries (except to the Company);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;any redemption, purchase or other acquisition by the Company or any of its Subsidiaries of
any shares of capital stock or securities of the Company or any of its Subsidiaries or any options,
warrants, calls or rights to acquire such shares or other securities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;any amendment or change to the Company&#146;s or any of its Subsidiaries&#146; articles of
incorporation, bylaws or equivalent organizational documents;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;any material change by the Company or any of its Subsidiaries to its accounting methods,
policies or practices;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;any issuance or grant by the Company or any of its Subsidiaries of any rights (including
stock appreciation rights, subscriptions, warrants, puts, calls, preemptive rights and options),
obligation to repurchase or redeem, or any other rights, or other agreements of any kind, relating
to, or the value of which is tied to the value of, any of the outstanding, authorized but not
issued, unauthorized or treasury shares of the capital stock or any other security of the Company
or any of its Subsidiaries, other than issuances of options pursuant to the Company Option Plans;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;any new employment agreements (or amendments or supplements to existing employment
agreements) by the Company or any of its Subsidiaries with any employee, officer or director of the
Company or any of its Subsidiaries, except for employment agreements required by applicable Legal
Requirements or the ordinary course and historical practice of the Company or its Subsidiaries with
respect to non-executive employees, or the grant of any increase in compensation (including
employee benefits) payable to any employee, officer or director of the Company or any of its
Subsidiaries, except for increases (A)&nbsp;in salary in the
</DIV>

<P align="center" style="font-size: 10pt">22
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ordinary course of business and consistent with past practice, or (B)&nbsp;as required by any
employment or other agreement, policy or plan in effect on December&nbsp;31, 2005;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;any Indebtedness incurred by the Company or any of its Subsidiaries, or any loans made or
agreed to be made by or to the Company or any of its Subsidiaries, other than in the ordinary
course of business and consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;any increase in or establishment of any bonus, severance or termination pay, deferred
compensation, pension, retirement, profit sharing, stock option or other employee benefit plan, or
any other increase in the compensation payable to any officers or key employees, except in the
ordinary course of business and consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;any acquisition of any capital stock or other ownership interest in any other Person;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;any loan (other than customary travel and expense advances) made by the Company or any of
its Subsidiaries to any officer or director of the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;any personal guarantee granted by the Company or any of its Subsidiaries on behalf of the
Company&#146;s or any of the Company&#146;s Subsidiaries officers or directors;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;any material damage, destruction or loss to any material asset of the Company or any of
its Subsidiaries, whether or not covered by insurance;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;any material tax election or any settlement or compromise of any material income tax
liability or refund; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;any agreement by the Company or any of its Subsidiaries to take any of the actions
described in the foregoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.9 </B><U><B>Licenses.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries, as applicable, holds all government licenses,
permits, certificates, franchises, approvals or other similar authorizations of all Governmental
Authorities, including all authorizations or clearances related to national security, in each case
that are material and necessary for such entity to own, lease or operate its properties and assets
and to conduct its business as presently conducted, including the promotion, marketing, and sale of
its current products (the &#147;<U>Licenses</U>&#148;). Each of the Licenses is valid and in full force and
effect, and the Company and each of its Subsidiaries are in compliance in all material respects
with the terms of the Licenses. No Governmental Authority has notified the Company or any of its
Subsidiaries (A)&nbsp;of its intent to modify, revoke, terminate or fail to renew any License, now or in
the future, or (B)&nbsp;that the Company or any of its Subsidiaries is in material violation of the
terms of any License and no action has been threatened with respect thereto. There is not pending
any proceeding, application, petition, objection or other pleading with any Governmental Authority
that questions the validity of any of the Licenses or that presents a substantial risk that, if
accepted or granted, would result in the revocation, cancellation, suspension or any adverse
modification of any of the Licenses.
</DIV>

<P align="center" style="font-size: 10pt">23
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.10 </B><U><B>Litigation; Compliance with Laws.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>Litigation</I>. As of the date hereof, there is no Action or series of related Actions
pending or, to the Knowledge of the Company, threatened, against the Company or any of its
Subsidiaries or any of their respective properties or rights that, if adversely determined,
reasonably would be expected to result in a loss to the Company or any of its Subsidiaries,
directly or indirectly, individually as to any Action, or in the aggregate as to any series of
related Actions, in excess of $2,500,000 or in a material change in, or limitation on, the business
practices or operations of the Company or any of its Subsidiaries. Neither the Company nor any of
its Subsidiaries is subject to any outstanding judgment, writ, decree, injunction or order of any
Governmental Authority that has had or reasonably would be expected to have, individually or in the
aggregate, a Material Adverse Effect. As of the date hereof, there are no Actions pending nor, to
the Knowledge of the Company, threatened, seeking or that reasonably would be expected to prevent,
hinder, modify, delay or challenge the transactions contemplated by this Agreement, including the
Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Compliance</I>. The Company and its Subsidiaries are in compliance in all material respects
with all Legal Requirements applicable to them or their respective businesses or operations and
have not received unresolved notification of any asserted present or past failure to so comply.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.11 </B><U><B>Employment Matters.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;There is no charge pending, and neither the Company nor any of its Subsidiaries has
received notice of any material threats, against the Company or any of its Subsidiaries alleging,
with respect to any employee or employees of the Company or any of its Subsidiaries, any violation
of any statute or regulation relating to employment and employment practices, any violation of OSHA
or other similar Legal Requirement, or any violation of any collective bargaining agreement, any
unlawful discrimination in employment practices or any unfair labor practices before any
Governmental Authority or arbitrator.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;There are no pending, and neither the Company nor any of its Subsidiaries has received
notice of any threatened, union organizing efforts, labor strikes, slow-downs or work stoppages
against the Company or any of its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No employees of the Company or any of its Subsidiaries are covered by any collective
bargaining agreement with respect to their employment with the Company or any of its Subsidiaries,
and no collective bargaining agreement or other similar labor union agreement for employees of the
Company or any of its Subsidiaries with respect to their employment with the Company or any of its
Subsidiaries is currently being negotiated or pending negotiation by the Company or any of its
Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;There has been no strike, work slowdown, employee lockout or concerted work stoppage with
respect to the business activities of the Company or any of its Subsidiaries during the last three
(3)&nbsp;years.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;There is no material complaint against the Company or any of its Subsidiaries issued by,
and neither the Company nor any of its Subsidiaries has received notice
</DIV>

<P align="center" style="font-size: 10pt">24
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">of any pending material complaint before, the National Labor Relations Board or any comparable
non-U.S. Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company and its Subsidiaries are in compliance in all material respects with all
applicable Legal Requirements relating to the employment of labor, including those related to
wages, hours, immigration and naturalization, collective bargaining and the payment and withholding
of Taxes and other sums as required by appropriate Governmental Authorities and have withheld and
paid to the appropriate Governmental Authority or are holding for payment not yet due to such
Governmental Authority all amounts required to be withheld from employees of the Company or any of
its Subsidiaries and are not liable for any arrears of wages, taxes, penalties or other sums for
failure to comply with any of the foregoing. The Company and its Subsidiaries have paid in full to
all employees or adequately accrued for in accordance with GAAP consistently applied all wages,
salaries, commissions, bonuses, benefits and other compensation due to or on behalf of such
employees, and neither the Company nor any of its Subsidiaries has received notice of any material
claim with respect to payment of wages, salary or overtime pay that has been asserted or is now
pending or threatened before any Governmental Authority with respect to any persons currently or
formerly employed by the Company or any of its Subsidiaries. Neither the Company nor any of its
Subsidiaries is a party to, or otherwise bound by, any executory consent decree with, or citation
by, any Governmental Authority relating to employees or employment practices. The Company and its
Subsidiaries are in compliance with the requirements of WARN and any similar Legal Requirements and
have no liabilities pursuant to WARN, in each case as determined without regard to any
terminations of employment that occur on or after the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.12 </B><U><B>Tax Matters.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company and each of its Subsidiaries has timely filed all material Tax Returns
required to be filed, and all such Tax Returns are true, correct and complete in all material
respects. The Company and each of its Subsidiaries has timely paid (or the Company has made
adequate reserves therefor in its financial statements included in the Company SEC Reports) all
Taxes due and payable (whether or not shown on such Tax Returns). The Company has made due and
sufficient accruals in the financial statements in accordance with GAAP in the latest Company SEC
Report for all Taxes of the Company or any of its Subsidiaries with respect to any taxable period,
or portion thereof, ending on or prior to the date of the latest Company SEC Report for which Tax
Returns have not yet been filed, or for which Taxes have been accrued but are not yet due and
owing. The Company and each of its Subsidiaries has withheld and paid all material Taxes required
to be withheld and paid in connection with amounts paid and owing to any employee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any of its Subsidiaries has received written notice of any
proposed or determined Tax deficiency or assessment by any Governmental Authority. As of the date
hereof there are no audits, examinations, requests for information or other administrative or
judicial proceedings pending or, to the Knowledge of the Company, threatened with respect to the
Company or any of its Subsidiaries and adequate provision for Taxes with respect to the audits,
examinations or other proceedings set forth in <U>Section&nbsp;3.12(b) of the Company Disclosure
Schedule</U> has been made and reflected on the financial statements in the Company SEC Reports.
Neither the Company nor any of its
</DIV>

<P align="center" style="font-size: 10pt">25
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiaries has granted any waiver of any statute of limitations with respect to, or any extension of a period for the
assessment of, any Tax.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company and each of its Subsidiaries is a member of the same affiliated group (within
the meaning of Section&nbsp;1504(a)(1) of the Code) for which the Company files a consolidated U.S.
federal income Tax Return as the common parent, and neither the Company nor any of its Subsidiaries
has been included in any other consolidated U.S. federal income Tax Return or other consolidated,
combined, unitary or similar group (other than a group of which the Company was the common parent)
for any taxable period for which the statute of limitations has not expired. Neither the Company
nor any of its Subsidiaries is a party to any indemnification, allocation or sharing agreement with
respect to Taxes that could give rise to a payment or indemnification obligation (other than
agreements among the Company and its Subsidiaries and other than customary Tax indemnification
contained in credit or other commercial agreements the primary purpose of which does not relate to
Taxes).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;There are no liens for Taxes upon any property or assets of the Company or any of the
Subsidiaries except liens for current Taxes not yet due and payable. Neither the Company nor any
of its Subsidiaries will be required to recognize income in a taxable period after the Effective
Time that is attributable to any transaction occurring in, or a change in accounting method made
for, any taxable period ending on or before the date of the Effective Time that resulted in a
deferred reporting of income from such transaction or from such change in accounting method.
Neither the Company nor any of its Subsidiaries has been a &#147;distributing corporation&#148; or a
&#147;controlled corporation&#148; in a distribution intended to qualify under Section&nbsp;355 of the Code within
the past five years. Neither the Company nor any of its Subsidiaries has made or is obligated to
make any payment that would not be deductible pursuant to Section 162(m) of the Code. Neither the
Company nor any of its Subsidiaries is required to make any disclosure to the IRS pursuant to
Section&nbsp;1.6011-4 of the Treasury Regulations promulgated under the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.13 </B><U><B>Real Property.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Section&nbsp;3.13(a) of the Company Disclosure Schedule</U> lists each real property that
is owned by the Company and each of its Subsidiaries (the &#147;<U>Owned Real Property</U>&#148;) and
identifies the material Owned Real Property (the &#147;<U>Material Owned Real Property</U>&#148;). Each of
the Company and its Subsidiaries has good, valid and marketable title to the Owned Real Property,
free and clear of all Liens, other than Permitted Liens. There are no outstanding Contracts for
the sale of any of the Owned Real Property and there are no leases, subleases, licenses,
concessions or any other contracts or agreements granting to any Person other than the Company or
any of its Subsidiaries any right to the possession, use, occupancy or enjoyment of any of the
Owned Real Property or any portion thereof. As of the date hereof, there are no existing, or to
the Knowledge of the Company, any threatened or pending Actions or applicable condemnation or
eminent domain proceedings (or proceedings in lieu thereof) affecting the Owned Real Property or
any portion thereof. To the Knowledge of the Company, there is no violation of any covenant,
condition, restriction, easement or agreement or order of any Governmental Authority relating to
the Material Owned Real Property, whether or not same are of record, that would, individually or in
the aggregate, materially and adversely interfere with the use, occupancy or operation thereof as
currently used, occupied and operated. To the
</DIV>

<P align="center" style="font-size: 10pt">26
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Knowledge of the Company, there are no encroachments or other facts or conditions affecting
any parcel of the Material Owned Real Property that would, individually or in the aggregate,
materially and adversely interfere with the use, occupancy or operation thereof as currently used,
occupied and operated. To the Knowledge of the Company, there are no filed mechanic&#146;s lien claims
against the Owned Real Property in respect of completed or ongoing construction projects that
relates to any failure to pay or any disputed payment by the Company or any of its Subsidiaries for
services utilized in the project exceeding, individually or in the aggregate, $1&nbsp;million.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Section&nbsp;3.13(b) of the Company Disclosure Schedule</U> lists each real property that
is leased or subleased by the Company or any of its Subsidiaries (the &#147;<U>Leased Real
Property</U>&#148;). Either the Company or one of its Subsidiaries is in possession of the property
that is the subject of the Leased Real Property, and holds good and valid leasehold interests in
the Leased Real Property free and clear of all Liens, other than Permitted Liens or Liens
encumbering a lessor&#146;s interest in the Leased Real Property incurred by the lessor. Each of the
Material Leases (A)&nbsp;is in full force and effect and is valid and binding on the Company or its
applicable Subsidiary, and (B)&nbsp;is enforceable against the Company or its applicable Subsidiary and,
to the Knowledge of the Company, against the other party or parties thereto, in accordance with its
terms, except as the same may be limited by applicable bankruptcy, insolvency, reorganization,
fraudulent conveyance, moratorium or similar laws affecting generally the enforcement of creditors&#146;
rights and remedies and general principles of equity, including any limitations on the availability
of the remedy of specific performance or injunctive relief regardless of whether specific
performance or injunctive relief is sought in a proceeding at law or in equity. (i)&nbsp;No material
default by the Company or any of its Subsidiaries exists under any Material Lease, (ii)&nbsp;to the
Knowledge of the Company, no material default by the landlord exists under any such Material Lease,
(iii)&nbsp;to the Knowledge of the Company, no circumstance exists which, with the giving of notice, the
passage of time or both, is reasonably expected to result in such a default by the Company or any
of its Subsidiaries under any such Material Lease, and (iv)&nbsp;to the Knowledge of the Company, no
circumstances exist which, with the giving of notice, the passage of time or both, is reasonably
expected to result in such a default by the landlord under any such Material Lease. True, correct
and complete copies of each of the Material Leases (and any amendments or modifications thereto)
have been delivered to the Purchaser. All rents, additional rents, common area charges, escrow
payments or similar charges or payments that are required to be made by the Company or any of its
Subsidiaries under the Material Leases and are due and payable prior to and including the date of
this Agreement have been paid in full without offset, claim or reduction. The transactions
contemplated by this Agreement do not require the consent or approval of, payment of a penalty to,
the landlord thereunder, or give the landlord thereunder the option to terminate any Material
Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;To the Knowledge of the Company, there are no contractual or legal restrictions or
physical defects that preclude or restrict, in a manner that, individually and in the aggregate,
reasonably could be expected materially and adversely affect the ability of the Company or any of
its Subsidiaries to use the Material Owned Real Property or the Material Leases (collectively, the
&#147;<U>Real Property</U>&#148;) for the purposes for which it is currently being used by the Company or
such Subsidiary.
</DIV>

<P align="center" style="font-size: 10pt">27
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;To the Knowledge of the Company, the Company and each applicable Subsidiary of the Company
has received all approvals of any Governmental Authority, including building, zoning,
administrative, occupational safety and health authorities, or such other approvals, including
licenses and certificates of occupancy, under any applicable Legal Requirements, required to be
obtained in connection with the ownership, use and operation of the Real Property for the purposes
for which it is currently being used by the Company or such Subsidiary, except for such, which if
not obtained would not, individually or in the aggregate, materially and adversely interfere with
the use, occupancy or operation thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;No portion of the Real Property has suffered any material damage by fire or other casualty
in the three (3)&nbsp;years immediately preceding the date of this Agreement that has not heretofore
been repaired and restored to the condition necessary for the Company or the applicable Subsidiary
of the Company to own and operate its business in accordance with good industry standards. As of
the date hereof, no portion of the Real Property is currently under construction in which the
Company or any Subsidiary of the Company is obligated to pay $100,000 or more to any architect,
contractor, subcontractor or materialmen for labor or materials to be performed, rendered or
supplied to or in connection with any Real Property after the date hereof with respect to any
individual property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.14 </B><U><B>Environmental Matters.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as has not had and reasonably would not be expected to have, individually or in the
aggregate, a Material Adverse Effect:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company and its Subsidiaries are and have been (except for such failures as have been
remedied) in compliance with Environmental Laws, which compliance includes obtaining, maintaining
and complying in all material respects with any and all Environmental Permits;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any of its Subsidiaries is subject to any pending Environmental
Claim or has received notice thereof that has not been fully resolved and, to the Knowledge of the
Company, there are no threatened Environmental Claims against the Company or any of its
Subsidiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor any of its Subsidiaries nor, to the Knowledge of the Company, any
other Person has, released, discharged, placed, stored, buried or dumped any Hazardous Materials
on, beneath or adjacent to the Real Property or any real property formerly owned, operated or
leased by the Company or any of its Subsidiaries that requires investigation, removal, remediation
or corrective action by the Company or any of its Subsidiaries under applicable Environmental Laws;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Neither the Company nor any of its Subsidiaries is subject to any Contract that requires
it to pay to, reimburse, guarantee, pledge, defend, indemnify or hold harmless any Person for or
against any environmental liabilities and costs relating to Hazardous Materials;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Neither the Company nor any of its Subsidiaries has entered into or agreed to any consent
decree, order, injunction, settlement or agreement under any Environmental Law, and neither the
Company nor any of its Subsidiaries or any of their properties is subject to any
</DIV>

<P align="center" style="font-size: 10pt">28
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">judgment, decree, injunction, settlement or order relating to compliance with any
Environmental Law or to cleanup, remediation or removal of Hazardous Materials under any
Environmental Law or to the Knowledge of the Company to investigation that reasonably would be
expected to result in a material liability;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;No employee of the Company or of its Subsidiaries in the course of his or her employment
with the Company or any such Subsidiary has been exposed to any Hazardous Materials in a manner the
Company expects would be likely to give rise to a claim against the Company or any Subsidiary of
the Company; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;To the Knowledge of the Company, neither the Company nor any of its Subsidiaries owns or
leases any real property containing any underground storage tanks, asbestos, equipment using PCBs,
underground injection wells, or septic tanks in which any Hazardous Materials have been disposed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.15 </B><U><B>Insurance.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The material assets and the business operations of the Company and each of its
Subsidiaries are insured against claims, losses or damages in amounts that are (i)&nbsp;sufficient to
satisfy the insurance coverage requirements of any applicable Legal Requirements and (ii)
consistent with the Company&#146;s and each such Subsidiary&#146;s past practices. All such material
policies are in full force and effect. The Company has made available to the Purchaser prior to
the date hereof copies of all such material insurance policies, each of which is listed in
<U>Section&nbsp;3.15 of the Company Disclosure Schedules</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Excluding insurance policies that have expired and been replaced in the ordinary course of
business, as of the date of this Agreement, to the Knowledge of the Company, no threat in writing
has been made to cancel (excluding cancellation upon expiration or failure to renew) any material
insurance policy of the Company or any of its Subsidiaries during the period of one year prior to
the date hereof. As of the date hereof, to the Knowledge of the Company, no event has occurred,
including the failure by the Company or any of its Subsidiaries to give any notice or information
or by giving any inaccurate or erroneous notice or information, that materially limits or impairs
the rights of the Company or any of its Subsidiaries under any such insurance policies.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.16 </B><U><B>Intellectual Property.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Section&nbsp;3.16(a) of the Company Disclosure Schedule</U> contains a true and complete
list of all (A)&nbsp;registrations or applications for registration, in respect of patents, trademarks,
service marks, U.S. copyrights and domain names, including the jurisdictions in which each such
item of Intellectual Property has been issued or registered or in which any such application for
such issuance and registration has been filed, owned by the Company or any of its Subsidiaries, and
(B)&nbsp;material unregistered trademarks and service marks owned by the Company or any of its
Subsidiaries. None of the Company or any of its Subsidiaries has any material registered
copyrights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Section&nbsp;3.16(b) of the Company Disclosure Schedule</U> contains a true and complete
list of (i)&nbsp;all Third Party Intellectual Property Agreements; (ii)&nbsp;any material licenses of
</DIV>

<P align="center" style="font-size: 10pt">29
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Intellectual Property granted by the Company or any of its Subsidiaries to any other Person;
(iii)&nbsp;any agreement by which the Company or any of its Subsidiaries grants any ownership right or
option to acquire an ownership right in any material Owned Intellectual Property; and (iv)&nbsp;all
material joint development agreements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;All agreements and licenses set forth in <U>Section&nbsp;3.16(b) of the Company Disclosure
Schedule</U> are valid and binding obligations of the Company or its Subsidiaries, are in full
force and effect, and are enforceable against the Company or its Subsidiaries, as applicable, in
accordance with their terms. The Company and its Subsidiaries are not, and to the Knowledge of the
Company, no party to any license, sublicense or other agreement listed in <U>Section&nbsp;3.16(b) of
the Company Disclosure Schedule</U> is, in breach or default, and no event has occurred which with
notice or lapse of time would constitute a breach or default or permit termination, modification or
acceleration of any license, sublicense or other agreement listed in <U>Section&nbsp;3.16(b) of the
Company Disclosure Schedule</U>, except to the extent that such breach, default, termination,
modification or acceleration has not had and reasonably would not be expected to have, individually
or in the aggregate, a material adverse effect on the Company and its Subsidiaries, taken as a
whole. Neither the Company nor any of its Subsidiaries has, in the past three years, sent a
written notice of breach or default to any party to any license, sublicense or other agreement
listed in <U>Section&nbsp;3.16(b) of the Company Disclosure Schedule</U>, except to the extent that
such breach or default has not had and reasonably would not be expected to have, individually or in
the aggregate, a material adverse effect on the Company and its Subsidiaries, taken as a whole. No
Action is pending or, to the Knowledge of the Company, is threatened against the Company or any of
its Subsidiaries that challenges the legality, validity or enforceability of any license,
sublicense or other agreement listed in <U>Section&nbsp;3.16(b) of the Company Disclosure Schedule</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;To the Knowledge of the Company, the Company and its Subsidiaries own or possess adequate
licenses or other rights to use all Company Intellectual Property, free and clear of all Liens
other than Permitted Liens and, in the case of Third Party Intellectual Property, as set forth in
the license or agreement therefor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;To the Knowledge of the Company, the conduct by the Company and its Subsidiaries of their
respective businesses as currently conducted, including research and development, product
development, manufacturing and marketing and sales activities, the manufacture, use or sale of any
product of the Company or any of its Subsidiaries, and the use by the Company or any of its
Subsidiaries of the Company Intellectual Property, does not conflict with, infringe, misappropriate
or otherwise violate the Intellectual Property rights of any other Person. The Company and its
Subsidiaries have not received in the past three years any notice or other communication (in
writing or otherwise) of any actual, alleged, possible or potential infringement, misappropriation,
dilution or unlawful use by the Company or any of its Subsidiaries of, any Intellectual Property or
other proprietary asset or rights of any other Person relating to any Company Intellectual Property
or any product of the Company or any of its Subsidiaries. There is no Action instituted, asserted
or pending or, to the Knowledge of the Company, threatened by any Person against the Company or any
Subsidiary of the Company nor any cease and desist or equivalent letter or any other notice of any
allegation received by the Company or any of its Affiliates, (i)&nbsp;challenging or affecting in any
material way the rights of the Company or any of its Subsidiaries in or seeking to deny or restrict
the use by the Company or
</DIV>

<P align="center" style="font-size: 10pt">30
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any Subsidiary of the Company of any of the Owned Intellectual Property or Third Party
Intellectual Property, (ii)&nbsp;alleging that any services provided by, processes used by, or products
manufactured or sold by the Company or any Subsidiary of the Company infringe, misappropriate or
otherwise violate the Intellectual Property right of any third party, or (iii)&nbsp;alleging that the
Third Party Intellectual Property is being licensed or sublicensed in conflict with the terms of
any license or other agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;To the Knowledge of the Company, there has been no unauthorized use, disclosure,
infringement, misappropriation or other violation of any Owned Intellectual Property or Third Party
Intellectual Property (exclusively licensed to the Company or any of its Subsidiaries) by any
Person, including any current or former officer, employee, independent contractor, consultant or
any other agent of the Company or any of its Subsidiaries. None of the Company or any of its
Subsidiaries has brought an Action in the past three years alleging infringement, dilution or
misappropriation of any Company Intellectual Property or breach of any license or agreement
involving Intellectual Property against any Person. <U>Section&nbsp;3.16 of the Company Disclosure
Schedule</U> lists all written opinions of counsel (outside or inside) relating to infringement,
invalidity or unenforceability of any Owned Intellectual Property received by the Company or any of
its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The Company or one of its Subsidiaries is the exclusive owner of the entire and
unencumbered right, title and interest in, to and under each asset and right embodied in or by the
Owned Intellectual Property (except for Permitted Liens, licenses granted by the Company or any of
its Subsidiaries to any Person and joint ownership interests in immaterial Intellectual Property).
None of the Company or any of its Subsidiaries nor, to the Knowledge of the Company, any Company
Intellectual Property is subject to any Action or outstanding decree, order, injunction, judgment,
ruling or stipulation restricting in any manner the use, transfer or licensing of such Intellectual
Property by the Company or any of its Subsidiaries, or that may affect or impair the validity, use
or enforceability of the Company Intellectual Property. None of the Company or any of its
Subsidiaries is subject to any agreement that restricts the use, transfer or licensing by the
Company or any of its Subsidiaries of any Owned Intellectual Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;To the Knowledge of the Company, other than the Owned Intellectual Property and the Third
Party Intellectual Property, there are no other items of Intellectual Property that are material to
the conduct of the respective businesses of the Company and its Subsidiaries as presently
conducted. The consummation of the transactions contemplated by this Agreement will not result in
the termination or impairment of any of the Company Intellectual Property or change the calculation
of the payment of royalties or fees to third parties, except to the extent that any such
termination, impairment or payment reasonably would not be expected to have, individually or in the
aggregate, a material adverse effect on the Company and its Subsidiaries, taken as a whole.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;All registrations with and applications to Governmental Authorities in respect of the
Owned Intellectual Property are valid and in full force and effect and, to the Knowledge of the
Company, enforceable, except with respect to registrations and applications abandoned in the
ordinary course of business. None of the Intellectual Property identified in <U>Section&nbsp;3.16(a)
of the Company Disclosure Schedule</U> has been abandoned unless so designated on such Schedule.
</DIV>

<P align="center" style="font-size: 10pt">31
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;The Company and its Subsidiaries have taken commercially reasonable measures to ensure
that all Intellectual Property created by employees, contractors and consultants of the Company or
any of its Subsidiaries (in their respective capacities as such) are Owned Intellectual Property
or, with respect to contractors and consultants, licensed to the Company or its Subsidiaries.
Furthermore, to the extent reasonably necessary to protect the Owned Intellectual Property that is
material to the conduct of the respective businesses of the Company and each of its Subsidiaries,
each of the Special Inventors, and all employees of the Company and each of its Subsidiaries
devoting more than thirty percent (30%) of his or her time and effort to technology research and
development activities, have executed written agreements with the Company or one of its
Subsidiaries to protect the Intellectual Property, and furthermore, to the Knowledge of the
Company, such Special Inventors, and all employees devoting more than thirty percent (30%) of their
time and effort to technology research and development activities, are not in violation or breach
of any term of any such written agreement that would materially impair the value to the Company of
such Owned Intellectual Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;The Company and its Subsidiaries have taken commercially reasonable measures to protect,
preserve and maintain the confidentiality and value of all Company Intellectual Property held in
confidence by the Company and its Subsidiaries, and to correct defects in the chain of title of
Owned Intellectual Property. The Company has taken commercially reasonable steps to secure the
Company IT Systems from unauthorized access or use thereof by any Person, and to provide for the
continued, uninterrupted and error free operation of the Company IT System.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Section&nbsp;3.17 </B><U><B>Employee Benefits.</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Section&nbsp;3.17(a) of the Company Disclosure Schedule</U> contains a true and complete
list of each Benefit Plan. The Company has made available to the Purchaser a copy of each Benefit
Plan (including amendments) or, where substantially similar arrangements exist, a sample copy. For
each Benefit Plan, the Company has furnished or made available to the Purchaser a true and complete
copy of each Benefit Plan document and where a Benefit Plan is unwritten, a written description of
the material terms thereof, and has delivered or made available to the Purchaser a true and
complete copy of the following: (i)&nbsp;each trust or other funding arrangement prepared in connection
with a Benefit Plan, (ii)&nbsp;each summary plan description and summary of material modifications (or a
description of any material oral communications) provided by the Company or any of its Subsidiaries
to any current or former employees, officers, directors, or other beneficiaries or their dependents
or spouses of the Company or any of its Subsidiaries concerning the extent of the benefits provided
under each Benefit Plan, (iii)&nbsp;the most recently filed IRS Form&nbsp;5500 for each Benefit Plan required
to file such report, (iv)&nbsp;the most recently received IRS determination letter or IRS prototype
opinion letter for each Benefit Plan that has received such IRS determination letter or IRS
prototype opinion letter and (v)&nbsp;the most recently prepared actuarial report or financial statement
in connection with each Benefit Plan required to prepare or distribute such actuarial report or
financial statement. Neither the Company nor any of its Subsidiaries has any express or implied
commitment (i)&nbsp;to create, incur liability with respect to or cause to exist any other employee
benefit plan, program or arrangement, (ii)&nbsp;to enter into any Contract to provide compensation or
benefits to any individual or (iii)&nbsp;to modify, change or terminate any Benefit Plan, other than
with respect to a modification, change or termination required by this Agreement, the
</DIV>

<P align="center" style="font-size: 10pt">32
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">transactions contemplated hereby, including the Merger, or ERISA or the Code or to otherwise
comply with applicable Legal Requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each Benefit Plan has been operated and administered in all material respects in
accordance with its terms and in material compliance with all applicable Legal Requirements
(including but not limited to ERISA and the Code). The Company and its Subsidiaries have performed
all material obligations required to be performed by them under, are not in any material respect in
default under or in violation of, and have no knowledge of any default or violation by any party
to, any Benefit Plan. No Action is pending or, to the Knowledge of the Company, threatened, with
respect to any Benefit Plan (other than routine claims for benefits in the ordinary course) and, to
the Knowledge of the Company, no fact or event exists that reasonably would be expected to give
rise to any such Action. No Benefit Plan that is intended to be qualified under Section 401(a) of
the Code is currently participating in or has participated in the Employee Plans Compliance
Resolution System set forth in Rev. Proc. 2003-44.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor any of its Subsidiaries (including any entity that during the past
six (6)&nbsp;years was a Subsidiary) or any ERISA Affiliate has now or at any time contributed to,
sponsored or maintained (i)&nbsp;a pension plan (within the meaning of Section&nbsp;3(2) of ERISA) subject to
Section&nbsp;412 of the Code or Title IV of ERISA, (ii)&nbsp;a multiemployer plan (within the meaning of
Section&nbsp;3(37) or 4001(a)(3) of ERISA) or (iii)&nbsp;a single employer pension plan (within the meaning
of Section&nbsp;4001(a)(15) of ERISA) for which the Company or any of its Subsidiaries could incur
liability under Section&nbsp;4063 or 4064 of ERISA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;No Benefit Plan is subject to Title IV of ERISA. No liability under Title IV of ERISA has
been incurred by the Company, its Subsidiaries or any ERISA Affiliate that has not been satisfied
in full.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The IRS has issued a favorable determination letter with respect to each of the Benefit
Plans that is intended to be qualified under Section&nbsp;401(A) of the Code and the related trust that
has not been revoked, and no fact or events exists that reasonably would be expected to result in
the revocation of such letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;With respect to any Benefit Plan that is a &#147;pension plan&#148; (within the meaning of Section
3(2) of ERISA), no &#147;prohibited transaction&#148; (within the meaning of Section&nbsp;4975 of the Code) has
occurred that reasonably could be expected to result in any material liability to the Company or
any of its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;All contributions, premiums or payments required to be made with respect to any Benefit
Plan have been made timely or the amount of such contribution, premium or payment is reflected on
the Company&#146;s balance sheet included in the Company&#146;s Form 10-K for the period ended December&nbsp;31,
2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<U>Section&nbsp;3.17(h) of the Company Disclosure Schedule</U> sets forth any individual
employment, termination, severance, change in control, retention, work for hire or similar
agreement existing prior to the date of this Agreement (x)&nbsp;between the Company or any of its U.S.
Subsidiaries, on the one hand, and any officer or employee of the Company or any of
</DIV>

<P align="center" style="font-size: 10pt">33
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">its U.S. Subsidiaries, on the other hand, or (y)&nbsp;between the Company or any of its
Subsidiaries, on the one hand, and any general manager of any of the Company&#146;s Subsidiaries, on the
other hand.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;None of the payments contemplated by the Benefit Plans of the Company or any of its
Subsidiaries would, individually or in the aggregate, constitute excess parachute payments (as
defined in Section&nbsp;280G of the Code) in connection with the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;Except to the extent required under ERISA Section&nbsp;601 et. seq. and Section&nbsp;4980B of the
Code, none of the Benefit Plans provides for or promises retiree medical, retiree disability or
retiree life insurance benefits to any current or former employee, officer or director of the
Company or any of its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;The Merger will not result in any payments, increase in benefits or costs, or acceleration
of rights under or in connection with any Foreign Plan, except as required under applicable Legal
Requirements. Other than as provided under applicable Legal Requirements, each Foreign Plan by its
terms may be amended or terminated by the Company or a Subsidiary of the Company. With respect to
each Foreign Plan: (i)&nbsp;each such plan that is intended to be tax-qualified or tax-registered or
approved is so qualified, registered or approved, and no action or failure to act on the part of
any Subsidiary of the Company reasonably would be expected to cause the loss of such qualification
or registration; (ii)&nbsp;those Foreign Plans that are required to be funded solely by the Company or
by a Subsidiary of the Company are substantially funded, and with respect to other Foreign Plans,
adequate reserves have been established on the accounting statements of the applicable entity; and
(iii)&nbsp;no other material liability or obligation of any Subsidiary of the Company exists with
respect to such Foreign Plans that has not been adequately reserved on the balance sheet of the
Company contained in the Company&#146;s Form 10-K filed with the SEC for the period ended December&nbsp;31,
2005, other than liabilities and obligations accrued in the ordinary course of business consistent
with past practice since December&nbsp;31, 2005 and, when filed, reflected in the applicable Company SEC
Report after December&nbsp;31, 2005. Each Foreign Plan has been maintained and operated in all material
respects in accordance with applicable Legal Requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.18 </B><U><B>Material Contracts.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subsections (i)&nbsp;through (x)&nbsp;of <U>Section&nbsp;3.18(a) of the Company Disclosure Schedule</U>
list the following types of Contracts to which the Company or any of its Subsidiaries is a party
(such Contracts as are required to be set forth in <U>Section&nbsp;3.18(a) of the Company Disclosure
Schedule</U> are referred to in this Agreement as the &#147;<U>Material Contracts</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) each &#147;material contract&#148; (as such term is defined in Item&nbsp;601(b)(10) of Regulation
S-K of the Securities Act) with respect to the Company (including its Subsidiaries);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) all supply Contracts under which the Company or any of its Subsidiaries has paid
$1&nbsp;million or more in the twelve (12)&nbsp;month period ended December&nbsp;31, 2005, or has
committed, as of the date hereof, to pay $1&nbsp;million or more over the twelve (12)&nbsp;month
period following the date of this Agreement;
</DIV>

<P align="center" style="font-size: 10pt">34
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all joint venture, partnership, strategic alliance and business acquisition or
divestiture Contracts;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) all Contracts relating to issuances of securities of the Company or any of its
Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) all distributor and all material broker, dealer, manufacturer&#146;s representative,
franchise and agency Contracts;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) all Contracts evidencing Indebtedness of $500,000 or more;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) all Contracts with any Governmental Authority under which the Company or any of
its Subsidiaries has received or paid $500,000 or more in the twelve (12)&nbsp;month period ended
December&nbsp;31, 2005, or under which such Governmental Authority has committed to pay to the
Company or any of its Subsidiaries or the Company or any of its Subsidiaires has committed
to pay, in each case, as of the date hereof, $500,000 or more over the twelve (12)&nbsp;month
period following the date of this Agreement, other than those Contracts for research
projects or for the sale of goods or services in the ordinary course of business to
municipal or government-owned hospitals, laboratories or state academic institutions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) all Contracts that limit, or purport to limit, the ability of the Company or any
of its Subsidiaries to compete in any line of business or with any Person or entity or in
any geographic area or during any period of time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) all Contracts that result in any Person holding a material power of attorney from
the Company or any of its Subsidiaries that relates to the Company, any such Subsidiary or
their respective businesses other than limited powers of attorney granted in the ordinary
course of business consistent with past practice; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) all other Contracts, whether or not made in the ordinary course of business, that
are material to the Company and its Subsidiaries, taken as a whole, the absence of which,
individually or in the aggregate, reasonably would be expected to result in a Material
Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;(i)&nbsp;Each Material Contract is a legal, valid and binding agreement of the Company or the
applicable Subsidiary, as the case may be, and, to the Knowledge of the Company, of the other
party(ies) thereto; (ii)&nbsp;none of the Company or any of its Subsidiaries is in material breach or
violation of, or material default under (nor, to the Knowledge of the Company, does there exist any
condition that, upon the passage of time or the giving of notice or both would result in a
violation or breach of, or constitute a default under, or give rise to any right of termination,
amendment, cancellation, acceleration or loss of benefits, or result in the creation of any
Encumbrance upon any of the properties or assets of the Company or any of its Subsidiaries), any
Material Contract; (iii)&nbsp;to the Knowledge of the Company, no other party is in material breach or
violation of, or material default under (nor does there exist any condition that, upon the passage
of time or the giving of notice or both would result in a violation or breach of, or constitute a
default under, or give rise to any right of termination, amendment, cancellation, acceleration or
loss of benefits, or result in the creation of any Encumbrance upon any of the
</DIV>

<P align="center" style="font-size: 10pt">35
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">properties or assets of the Company or any of its Subsidiaries), any Material Contract; (iv)
none of the Company or any of its Subsidiaries has received any notice of default or notice to cure
under any Material Contract that remains uncured; and (v)&nbsp;neither the execution of this Agreement
nor the consummation of any transaction contemplated by this Agreement, including the Merger, shall
constitute a default under, give rise to cancellation rights under, or otherwise adversely affect
any of the rights of the Company or any of its Subsidiaries under any Material Contract. The
Company has furnished or made available to the Purchaser true and complete copies of all Material
Contracts, including any amendments thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.19 </B><U><B>Regulatory Matters. </B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company and its Subsidiaries have established and administer one or more compliance
programs (including a written compliance policy) applicable to the Company and its Subsidiaries (i)
to assist the Company and its Subsidiaries and the directors, officers and employees of the Company
and its Subsidiaries in complying with applicable Legal Requirements (including those administered
by the FDA or comparable Governmental Authority) applicable to the Company, its Subsidiaries or
their respective businesses and (ii)&nbsp;to provide compliance policies and training to appropriate
persons governing applicable areas for medical device companies (including pre-clinical and
clinical testing, product design and development, product testing, product manufacturing, product
labeling, product storage, pre-market clearance and approval, advertising and promotion, product
sales and distribution, medical device recall and reporting regulations and record keeping).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as disclosed in the Company SEC Reports, the Company and its Subsidiaries are in
compliance in all material respects with the provisions of all Legal Requirements of applicable
Governmental Authorities relating to the regulation of the Company&#146;s and its Subsidiaries&#146;
products, including the FDC Act, the PHS Act, and all rules and regulations promulgated thereunder,
except for instances of noncompliance that have not had and reasonably would not be expected to
have, individually or in the aggregate, a Material Adverse Effect. Except as disclosed in the
Company SEC Reports, with respect to the marketing of products by the Company or any of its
Subsidiaries, all applications, submissions, information, claims and statistics and other data and
conclusions derived therefrom, utilized as the basis for or submitted in connection with any and
all requests for authorizations, approvals, certificates, waivers, certifications, clearances,
exemptions, notifications, consents, orders, registrations, listings, licenses or permits of any
applicable Governmental Authority, including the FDA and the USDA, relating to the Company, its
Subsidiaries, their respective businesses and products, when submitted to the applicable
Governmental Authority, were true, complete and correct in all material respects as of the date of
submission and any necessary or required updates, changes, corrections or modification to such
applications, submissions, information and data have been submitted to the applicable Governmental
Authority. All product claims made by the Company or its Subsidiaries with respect to the
Company&#146;s or its Subsidiaries&#146; products are valid, supported by proper research, design, testing,
analysis and disclosure, and are permitted by applicable Legal Requirements administered by the
FDA, USDA or comparable non-U.S. Governmental Authority, except for such failures as have not had
and reasonably would not be expected to have, individually or in the aggregate, a Material Adverse
Effect.
</DIV>

<P align="center" style="font-size: 10pt">36
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company&#146;s and its Subsidiaries&#146; activities and relevant facilities, as well as, to the
Knowledge of the Company, its suppliers, distributors and other intermediaries, are in compliance
with all applicable Legal Requirements of any U.S. Governmental Authority that govern the marketing
of products by the Company or any of its Subsidiaries, including the FDC Act and the PHS Act and
all implementing regulations thereunder, including the registration, listing, labeling, reporting
and manufacturing requirements of 21 C.F.R. Parts 803, 806, 807, 809, 812, 814 and 820, all to the
extent applicable to in vitro diagnostic devices and accessories, and comparable Legal Requirements
of any applicable non-U.S. Governmental Authority of Brazil, Japan, Canada, the United Kingdom,
Germany, France or comparable European Union directives, and to the Knowledge of the Company, any
other non-U.S. jurisdictions, except for noncompliance that has not had and reasonably would not be
expected to have, individually or in the aggregate, a material adverse effect on the Company or
applicable Subsidiary of the Company. Except as disclosed in the Company SEC Reports, neither the
Company nor any of its Subsidiaries is subject to any obligation arising under any consent decree,
consent agreement, or warning letter issued by or entered into with the FDA or other notice,
response or commitment made to the FDA or any comparable Governmental Authority. The Company has
disclosed to the Purchaser any warning letters, untitled (or &#147;notice of violation&#148;) letters, or
similar notices, or other correspondence relating to the Company&#146;s or any of its Subsidiaries&#146;
compliance status under applicable Legal Requirements of any Governmental Authority that govern the
marketing of products by the Company or any of its Subsidiaries within the last two (2)&nbsp;years.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;All products being manufactured, distributed, or developed by the Company or any of its
Subsidiaries that are subject to the jurisdiction of the FDA or any comparable non-U.S.
Governmental Authority are being manufactured, labeled, stored, tested, distributed, and marketed
in compliance with all applicable Legal Requirements of any Governmental Authority that govern the
marketing of products by the Company or any of its Subsidiaries, except for instances of
noncompliance that have not had and reasonably would not be expected to have, individually or in
the aggregate, a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;There are no clinical trials or studies being conducted by or on behalf of the Company or
any of its Subsidiaries. Except as disclosed in the Company SEC Reports, all pre-clinical trials
and clinical trials conducted by or on behalf of the Company or any of its Subsidiaries have been,
and are being conducted in material compliance with the applicable Legal Requirements relating to
protection of human subjects contained in 21 C.F.R. Parts 50, 54 and 56 and, where applicable, the
Declaration of Helsinki, except for instances of noncompliance that have not had and reasonably
would not be expected to have, individually or in the aggregate, a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except as disclosed in the Company SEC Reports, to the Knowledge of the Company, neither
the Company nor any of its Subsidiaries, nor their respective officers, employees or agents has
committed any act, made any statement, or failed to make any statement, that would be reasonably
expected to provide a basis for the FDA to withdraw product approval or clearance or to invoke its
policy respecting &#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&#148;
set forth in 56 Fed. Reg. 46191 (September&nbsp;10, 1991) and any amendments thereto, or provide a basis
for a U.S. Governmental Authority to bring an action against the Company or any of its Subsidiaries
for a violation of 18 U.S.C. Section&nbsp;1001 or any
</DIV>

<P align="center" style="font-size: 10pt">37
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">other comparable Legal Requirement of any applicable Governmental Authority for making false
statements to the FDA..
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Except as disclosed in the Company SEC Reports, neither the Company nor any Subsidiary of
the Company has been convicted of any crime or engaged in any conduct that could result in a
debarment under 21 U.S.C. Section&nbsp;335a, 48 C.F.R. Subpart 9.4, or under any similar Legal
Requirement, or under any exclusion from participation in general health care programs of the
United States pursuant to 42 U.S.C. Section&nbsp;1320a-7.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Except as disclosed in the Company SEC Reports filed prior to the date hereof, there are
no proceedings pending with respect to a violation by the Company or any of its Subsidiaries of the
FDC Act or the PHS Act or their implementing regulations, the Controlled Substance Act or any other
similar legislation or regulation promulgated by any other Governmental Authority that reasonably
would be expected to result in criminal liability.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;With respect to the year ended December&nbsp;31, 2005, sales by the Company and its
Subsidiaries with respect to Contracts with the U.S. Government did not exceed $3&nbsp;million. To the
Knowledge of the Company, the Company and its Subsidiaries are in material compliance with the
terms and conditions of such Contracts with the U.S. Government and applicable Legal Requirements
with respect to such Contracts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.20 </B><U><B>Affiliate Transaction.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in the Company SEC Reports, no director or officer of the Company or any
of its Subsidiaries has, directly or indirectly, (i)&nbsp;an economic interest in any Person that has
furnished or sold, or furnishes or sells, services or products that the Company or any of its
Subsidiaries furnishes or sells; (ii)&nbsp;an economic interest in any Person that purchases from or
sells or furnishes to, the Company or any of its Subsidiaries, any goods or services; (iii)&nbsp;a
beneficial interest in any Contract disclosed pursuant to <U>Section&nbsp;3.13</U>, <U>Section
3.16</U> or <U>Section&nbsp;3.18</U> hereof; or (iv)&nbsp;served as an officer, director, employee or
consultant of or otherwise receives remuneration from, any Person that is, or has engaged in
business as, a competitor, lessor, lessee, customer or supplier of the Company or any of its
Subsidiaries; <I>provided </I>that ownership of no more than one percent (1%) of the outstanding voting
stock of a publicly traded corporation shall not be deemed an &#147;economic interest in any Person&#148; for
purposes of this <U>Section&nbsp;3.20</U>. Neither the Company nor any of its Subsidiaries has, since
October&nbsp;1, 2002, extended or maintained credit, arranged for the extension of credit or renewed an
extension of credit in the form of a personal loan to or for any director or executive officer (or
equivalent thereof) of the Company or such Subsidiary (and with respect to Subsidiaries remains
outstanding).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.21 </B><U><B>Board Recommendation.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of the Company, by resolution duly adopted by unanimous vote at a
meeting duly called and held, and at which all directors were present, which resolution has not
subsequently been rescinded or modified in any manner whatsoever, has (i)&nbsp;determined that this
Agreement and the Merger are fair to and in the best interests of the shareholders of the Company,
(ii)&nbsp;approved this Agreement and the transactions contemplated hereby, including the
</DIV>

<P align="center" style="font-size: 10pt">38
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> Merger, (iii)
resolved to recommend that the holders of shares of the Company
Common Stock approve this Agreement and the Merger and (iv)&nbsp;directed that approval of this Agreement and
the Merger be submitted to the Company&#146;s shareholders at the Company Shareholders&#146; Meeting. The
actions described in this <U>Section&nbsp;3.21</U> and the favorable recommendation to the Company&#146;s
shareholders contemplated thereby are sometimes collectively referred to in this Agreement as the
&#147;<U>Company Board Recommendation</U>.&#148; The representations contained in this <U>Section&nbsp;3.21</U>
shall not prohibit actions permitted pursuant to <U>Section&nbsp;5.5</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.22 </B><U><B>Proxy Statement. </B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for information provided by the Purchaser in writing expressly for inclusion therein,
none of the information contained or incorporated by reference in the Proxy Statement will at the
time of the mailing thereof or of the meeting at which the Company Shareholder Approval is to be
obtained, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.23 </B><U><B>Title to Personal Property.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries has good and valid title to, or, in the case of leased
personal properties and assets, valid leasehold or subleasehold interests in, all of its material
personal properties and assets used or held for use in the business of the Company and its
Subsidiaries, free and clear of any Liens, except for Permitted Liens.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.24 </B><U><B>Customers and Suppliers.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;3.24(a) of the Company Disclosure Schedule</U> sets forth a true and complete list
of the customers representing over $3&nbsp;million in annual sales in 2005 in the United States and over
$1&nbsp;million in annual sales in 2005 in each of the United Kingdom, Germany, Italy and Brazil (such
customers, the &#147;<U>Larger Customers</U>&#148;). As of the date of this Agreement, no distributor or
other customer (excluding the Company&#146;s Subsidiaries) accounted for more than ten percent (10%) of
the Company&#146;s consolidated revenues during the twelve (12)&nbsp;month period preceding the date of this
Agreement. As of the date hereof, no Larger Customer, to the Knowledge of the Company, has
indicated its intention to cancel or otherwise terminate its relationship with the Company or any
of its Subsidiaries or to reduce materially its purchases from the Company or any of its
Subsidiaries. Other than those suppliers identified in <U>Section&nbsp;3.24(b) of the Company
Disclosure Schedule</U>, there are no material suppliers to the Company or any of its Subsidiaries.
As of the date hereof, no supplier identified in <U>Section&nbsp;3.24(b) of the Company Disclosure
Schedule</U>, to the Knowledge of the Company, has indicated its intention to cancel or otherwise
terminate its relationship with the Company or any of its Subsidiaries or to reduce materially its
sale to the Company or any of its Subsidiaries of any products, equipment, goods or services.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.25 </B><U><B>Company Products and Services.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has, in the past twelve (12)&nbsp;months,
experienced a material increase in product warranty claims or returns, and neither the Company nor
any of its Subsidiaries has any material liabilities or obligations in excess of customary reserves
therefor for replacement or repair of the products sold by them.
</DIV>

<P align="center" style="font-size: 10pt">39
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.26 </B><U><B>Certain Business Practices.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in the Company SEC Reports, to the Knowledge of the Company, none of the
Company, any of its Subsidiaries or any directors or officers, agents or employees of the Company
or any of its Subsidiaries or minority-owned subsidiaries, has (i)&nbsp;violated the Foreign Corrupt
Practices Act of 1977, as amended (the &#147;<U>FCPA</U>&#148;); (ii)&nbsp;violated the &#147;Federal Anti-kickback
Statute,&#148; 42 U.S.C. Section&nbsp;1320a-7b, or any similar Legal Requirement; or (iii)&nbsp;violated the U.S.
False Claims Act,&#148; 31 U.S.C. &#167;3729, or any similar U.S. Legal Requirement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.27 </B><U><B>Opinion of Financial Advisor.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The board of directors of the Company received the opinion of Lehman Brothers to the effect
that, and based upon and subject to the factors and assumptions set forth therein, from a financial
point of view, the Merger Consideration to be offered to the shareholders of the Company in the
Merger is fair to such shareholders, and a copy of the written opinion will be provided to the
Purchaser following the date of this Agreement. The Company has been advised that Lehman Brothers
will consent to a description and inclusion of the opinion in the document required to be filed
with the Securities and Exchange Commission in connection with the Merger and to references to
Lehman Brothers in such document, provided that any such description and references are approved in
advance by Lehman Brothers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;3.28 </B><U><B>Finders and Brokers.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No broker, finder or investment banker, financial advisor or other Person, other than Lehman
Brothers, is entitled to any broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or
commission in connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of the Company or its Subsidiaries.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IV</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND MERGER SUB</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Purchaser and Merger Sub, jointly and severally, hereby represent and warrant to the
Company as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.1 </B><U><B>Organization and Qualification.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the Purchaser and Merger Sub is a corporation duly formed, validly existing and in
good standing under the laws of its jurisdiction of incorporation or organization, and has all
requisite corporate power to own, lease and operate its properties and to carry on its business as
currently conducted. Each of the Purchaser and Merger Sub is duly qualified or licensed to do
business as a foreign corporation and is in good standing in each jurisdiction where such
qualification is necessary, with such exceptions as would not have a material adverse effect on the
Purchaser&#146;s or Merger Sub&#146;s ability to consummate the transactions contemplated by this Agreement.
True and correct copies of Merger Sub&#146;s articles of incorporation and bylaws, all as amended to
date, have been delivered or made available to the Company.
</DIV>

<P align="center" style="font-size: 10pt">40
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.2 </B><U><B>Authorization.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the Purchaser and Merger Sub has all requisite corporate power and corporate authority
to execute and deliver this Agreement, to perform its obligations under this Agreement and to
consummate the transactions contemplated hereby. The execution, delivery and performance by each
of the Purchaser and Merger Sub of this Agreement and the consummation by each of the Purchaser and
Merger Sub of the transactions contemplated hereby have been duly authorized by each of the
Purchaser and Merger Sub. This Agreement has been duly authorized, executed and delivered by each
of the Purchaser and Merger Sub, and constitutes the legally valid and binding obligation of each
of the Purchaser and Merger Sub, as the case may be (assuming due authorization, execution and
delivery of this Agreement by the Company), enforceable against each of the Purchaser and Merger
Sub in accordance with its terms, except as the same may be limited by applicable bankruptcy,
insolvency, reorganization, fraudulent conveyance, moratorium or similar laws affecting generally
the enforcement of creditors&#146; rights and remedies and general principles of equity, including any
limitations on the availability of the remedy of specific performance or injunctive relief
regardless of whether specific performance or injunctive relief is sought in a proceeding at law or
in equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.3 </B><U><B>Capitalization and Share Ownership.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The authorized capital stock of Merger Sub consists of 3,000 shares of common stock, par value
$0.01 per share, 100 shares of which are duly authorized, validly issued and outstanding, fully
paid, nonassessable and owned by the Purchaser free and clear of all Liens. No class of capital
stock of Merger Sub is subject to preemptive (or similar) rights. Merger Sub was formed solely for
the purpose of engaging in a business combination transaction with the Company and has engaged in
no other business activities and has conducted its operations solely as contemplated hereby.
Except as described in the first sentence of this <U>Section&nbsp;4.3</U>, Merger Sub has not issued
any capital stock or any options, warrants or other rights to acquire capital stock (or securities
convertible into or exercisable or exchangeable for capital stock). Except as provided in this
Agreement, there are no options, warrants or other rights to acquire capital stock or other equity
or voting interests in Merger Sub or securities convertible into or exercisable or exchangeable for
capital stock or other equity or voting interests in Merger Sub. Except as provided in this
Agreement, no Person has any right to acquire any interest in the business or assets of Merger Sub
(including any rights of first refusal or similar right).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.4 </B><U><B>Governmental Authorization; Noncontravention.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The execution, delivery and performance by each of the Purchaser and Merger Sub of this
Agreement and the consummation by each of the Purchaser and Merger Sub of the transactions
contemplated hereby requires no consent, approval, authorization, qualification, order or permit
of, action by or in respect of, or filing with or notification to, any Governmental Authority,
other than (i)&nbsp;the filing or registration of the Agreement of Merger with the Secretary of State of
the State of California and appropriate documents with the relevant authorities of other states in
which Merger Sub is qualified to do business, (ii)&nbsp;compliance with any applicable requirements of
the HSR Act and the German Regulation, if required, and other requirements under the antitrust or
anti-competition laws of other foreign countries, (iii)&nbsp;compliance with any applicable requirements
of the Securities Act, the Exchange Act,
</DIV>

<P align="center" style="font-size: 10pt">41
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">paragraph fifteen (15)&nbsp;of the German Securities Trading Act (WpHG) and any other applicable securities
law Legal Requirements, (iv)&nbsp;compliance with the rules and regulations of any applicable stock
exchanges or automated quotation system and (v)&nbsp;any actions or filings the absence of which would
not have, individually or in the aggregate, a material adverse effect on the Purchaser&#146;s or Merger
Sub&#146;s ability to consummate the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The execution, delivery and performance by each of the Purchaser and Merger Sub of this
Agreement and the consummation by each of the Purchaser and Merger Sub of the transactions
contemplated hereby do not and will not (i)&nbsp;contravene, conflict with or result in any violation or
breach of any provision of the articles of incorporation or bylaws or similar organizational
documents of either the Purchaser or Merger Sub, (ii)&nbsp;contravene, conflict with or result in a
violation or breach of any provision of any Legal Requirement applicable to the Purchaser or Merger
Sub or by which their respective properties or assets are bound, and (iii)&nbsp;require any consent or
other action by any Person under, constitute a default (or an event that, with or without notice or
lapse of time or both, would constitute a default) under, or cause or permit the termination,
cancellation, acceleration, triggering or other change of any right or obligation or the loss of
any benefit to which the Purchaser or Merger Sub is entitled under any provision of any Contract
binding upon the Purchaser or Merger Sub, other than such exceptions in the case of clauses (ii)
and (iii)&nbsp;as would not have, individually or in the aggregate, a material adverse effect on the
Purchaser&#146;s or Merger Sub&#146;s ability to consummate the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.5 </B><U><B>Litigation</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the Purchaser&#146;s knowledge, as of the date hereof, there are no suits, claims, actions or
proceedings (at law or in equity) pending or threatened, seeking to (or that reasonably would be
expected to) prevent, modify, delay or challenge the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.6 </B><U><B>Ownership of Company Common Stock.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Purchaser nor Merger Sub beneficially owns, directly or indirectly, any shares of
Company Common Stock or is a party to any Contract (other than this Agreement) for the purpose of
acquiring, holding, voting or disposing of any shares of Company Common Stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.7 </B><U><B>Finder and Brokers.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No broker, finder or investment banker, financial advisor or other Person, other than
JPMorgan, the fees and expenses of which will be paid by the Purchaser, is entitled to any
broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or commission in connection with the
transactions contemplated by this Agreement based upon arrangements made by or on behalf of the
Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;4.8 </B><U><B>Available Funds.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Purchaser has, and at the Effective Time will have, available the funds necessary to pay
the Merger Consideration for all of the Company Common Stock pursuant to the Merger, to
</DIV>

<P align="center" style="font-size: 10pt">42
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">pay the amounts contemplated by <U>Section&nbsp;2.9</U> and to pay all fees and expenses in
connection therewith.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE V</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>PRE-CLOSING COVENANTS AND ADDITIONAL AGREEMENTS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.1 </B><U><B>Conduct of Business.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During the period from the date of this Agreement to the earlier of the Effective Time or the
Termination Date, except as specifically contemplated or permitted by this Agreement or with the
prior written consent of the Purchaser, (provided that in considering any such request for consent
pursuant to this Section&nbsp;5.1, the Purchaser shall act reasonably) the Company shall, and shall
cause its Subsidiaries to, carry on their respective businesses in the ordinary course consistent
with past practice and use their respective reasonable best efforts to preserve intact their
assets, Intellectual Property, Licenses, present business organizations, lines of business, rights
and franchises and their relationships with customers, suppliers, employees and others having
business dealings with them. In addition and without limiting the generality of the foregoing,
except (i)&nbsp;as specifically permitted or required by this Agreement, (ii)&nbsp;as set forth in Section
5.1 of the Company Disclosure Schedule, (iii)&nbsp;as required by applicable Legal Requirements or the
rules or regulations of the New York Stock Exchange or (iv)&nbsp;unless the Purchaser expressly consents
in writing in advance (provided that in considering any such request for consent pursuant to this
Section&nbsp;5.1, the Purchaser shall act reasonably), the Company will not, and will cause each of its
Subsidiaries not to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) (A)&nbsp;amend, modify or terminate any Material Contract, except for non-substantive
amendments or modifications in the ordinary course of business consistent with past
practice, (B)&nbsp;waive, release or assign any material rights or claims under any Material
Contract, except in the ordinary course of business consistent with past practice or (C)
except in the ordinary course of business consistent with past practice, enter into any
Material Contracts or material transactions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) (A)&nbsp;abandon, sell, assign or grant any security interest in or to any material
Owned Intellectual Property, Third Party Intellectual Property or Third Party Intellectual
Property Agreement, (B)&nbsp;grant to any third party any license, sublicense or covenant not to
sue with respect to any material Owned Intellectual Property or Third Party Intellectual
Property, other than to customers in the ordinary course of business consistent with past
practice, (C)&nbsp;other than in the ordinary course of business consistent with past practice,
develop, create or invent any material Intellectual Property jointly with any third party
(other than under an agreement that has been disclosed to the Purchaser prior to the date
hereof), (D)&nbsp;voluntarily disclose, or authorize any disclosure of, any confidential Owned
Intellectual Property, unless such Owned Intellectual Property is subject to a
confidentiality or non-disclosure covenant protecting against further disclosure thereof or
(E)&nbsp;amend, modify or terminate any material Third Party Intellectual Property Agreement,
except for non-substantive amendments or modifications in the ordinary course of business
consistent with past practice;
</DIV>

<P align="center" style="font-size: 10pt">43
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sell, lease, mortgage, encumber or otherwise dispose of or subject to a Lien
(other than a Permitted Lien), any of its or its Subsidiaries properties or assets or any
interests therein (including securitizations), other than sales of inventory or licenses of
finished goods in the ordinary course of business consistent with past practice or the
dispositions of assets in the ordinary course of business consistent with past practice that
do not, in the aggregate, exceed $500,000 (measured by the higher of the book value of all
such assets sold or the proceeds from the sale thereof);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) amend or change its articles of incorporation, bylaws or equivalent organizational
documents;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) split, combine, subdivide or reclassify any shares of its capital stock or other
equity interests or declare, set aside, make or pay any dividend (other than the Company&#146;s
regular quarterly dividend which shall not be in excess of $0.07 per share) or other
distribution (whether in cash, stock or property or any combination thereof), in respect of
its or its Subsidiaries&#146; capital stock, or redeem, repurchase or otherwise acquire or offer
to redeem, repurchase or otherwise acquire any of its securities or any securities of the
Company or any of its Subsidiaries, except for (A)&nbsp;dividends paid by any Subsidiary that is,
directly or indirectly, wholly owned by the Company, (B)&nbsp;dividends paid by any Subsidiary
that is not, directly or indirectly, wholly owned by the Company in the ordinary course of
business consistent with past practice, and (C)&nbsp;issuances of shares of Company Common Stock
upon the exercise of Company Stock Options which are outstanding as of the date of this
Agreement and in accordance with their terms in effect on the date of this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) issue, deliver, sell, encumber or otherwise dispose of, or authorize the issuance,
delivery, sale, encumbrance or disposition of, any shares of its capital stock of any class
or other equity interests or any securities convertible into or exercisable for, or any
rights, warrants or options to acquire, any such capital stock or other equity interests,
other than the issuance of shares of the Company Common Stock upon the exercise of the
Company Stock Options, under Company Option Plans, which are outstanding as of the date
hereof in accordance with their present terms;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) grant any stock options, stock appreciation rights, phantom stock rights, profit
participation rights or other equity-based compensation benefits or rights to acquire
securities or accelerate, amend or change the period of exercisability or vesting of options
or other rights granted under the Company Option Plans or authorize cash payments in
exchange for any options or other rights granted under any of such Company Option Plans,
except as expressly permitted by this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) (A)&nbsp;increase benefits under any Benefit Plan or Foreign Plan, except in the
ordinary course of business consistent with past practice, (B)&nbsp;increase funding under (or
take action to fund) any Benefit Plan or Foreign Plan, except in the ordinary course of
business consistent with past practice or as required by applicable Legal Requirements, (C)
establish, adopt, enter into, amend (other than any amendment that would result in a
reduction in the costs of such Benefit Plan or Foreign Plan or is required to satisfy
applicable Legal Requirements) or terminate any Benefit Plan or Foreign Plan or any
</DIV>

<P align="center" style="font-size: 10pt">44
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">plan, agreement, program, policy, trust, fund or other arrangement that would be a
Benefit Plan or Foreign Plan if it were in existence as of the date of this Agreement, (D)
grant or agree to grant any increase in the rates of salaries or compensation payable
(including grants of stock options), or provide other benefits not generally available to
all employees, to any director, officer or employee except, with respect to non
officer/director employees, in the ordinary course of business consistent with past practice
(and other than as required by Legal Requirements or pursuant to Contracts in effect as of
the date hereof that are disclosed in <U>Section&nbsp;5.1(viii) of the Company Disclosure
Schedule</U>), (E)&nbsp;loan any money to any director, officer or employee, or any member of
their immediate families (as defined in Regulation&nbsp;S-K, Item&nbsp;404), except for employee loans
made in accordance with past practice that do not exceed $10,000 individually or $50,000 in
the aggregate, (F)&nbsp;other than as required by applicable Legal Requirements, change any
actuarial or other assumption used to calculate funding obligations with respect to any
pension plan or change the timing or manner in which contributions to any pension plan are
made or the basis on which such contributions are determined except as required by
applicable Legal Requirements, (G)&nbsp;except as required by applicable Legal Requirements or in
accordance with the Company&#146;s severance practice described in <U>Section&nbsp;3.17(a) and
3.17(k) of the Company Disclosure Schedule</U> implemented in the ordinary course of
business consistent with past practice, take any action that could give rise to severance
benefits payable to any officer, director or employee of the Company or any of its
Subsidiaries, including as a result of consummation of any of the transactions contemplated
by this Agreement or the Shareholder Agreement; or (H)&nbsp;hire new employees, or terminate the
employment of existing employees, except in the ordinary course of business consistent with
past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) directly or indirectly acquire, make any investment in, or make any capital
contributions or loans to, any Person (other than in or to a Subsidiary of the Company),
except for employee loans made in accordance with past practice that do not exceed $10,000
individually or $50,000 in the aggregate;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) acquire any asset or make any capital expenditures in excess of $500,000 in any one
instance or $5,000,000 in the aggregate, except for purchases of raw materials, components
or supplies in the ordinary course of business consistent with past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) incur or suffer to exist any Indebtedness or guarantee any such Indebtedness,
guarantee any indebtedness of others, enter into any &#147;keep-well&#148; or other agreement to
maintain any financial statement condition of another Person or enter into any arrangement
having the economic effect of any of the foregoing, other than (A)&nbsp;Indebtedness incurred in
the ordinary course of business consistent with past practice and in amounts not to exceed
$250,000 at any time outstanding, (B)&nbsp;draws under the Company&#146;s existing line of credit upon
the terms and subject to the conditions thereof in effect on the date of this Agreement, (C)
Indebtedness between the Company and any of its direct or indirect wholly-owned
Subsidiaries, (D)&nbsp;draws by a Subsidiary of the Company against its credit facility upon the
terms and subject to the conditions thereof in effect as of the date of this Agreement and
(E)&nbsp;loans, advances or short-term Indebtedness made or incurred in connection with the
purchase of raw materials,
</DIV>

<P align="center" style="font-size: 10pt">45
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">equipment and supplies in the ordinary course of business consistent with past practice
and in amounts and on terms consistent with past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii) pay, discharge, settle or satisfy any material claim, liability or obligation
(absolute, accrued, asserted or unasserted, contingent or otherwise) or waive or assign any
claims or rights of substantial value or any other benefit, except for the payment,
discharge, settlement, satisfaction, waiver or assignment, in the ordinary course of
business consistent with past practice or in accordance with their terms as in effect on the
date hereof;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii) settle or compromise any Action (whether or not commenced prior to the date of
this Agreement), other than settlements or compromises of Actions where the amount paid by
the Company or any of its Subsidiaries (after giving effect to insurance proceeds actually
received) in settlement or compromise does not exceed the Company&#146;s reserves therefor on its
balance sheet included in the Company&#146;s Form 10-K for the period ended December&nbsp;31, 2005, or
with respect to any individual Action that does not exceed $500,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv) make or change any material income Tax election, amend any material income Tax
election, change any annual Tax accounting period, change in any material respect any method
of Tax accounting, file any material amendment to a Tax Return, enter into any closing
agreement relating to any material Tax, surrender any right to claim a material Tax refund,
or consent to any extension or waiver of the statute of limitations period applicable to any
material Tax claim or assessment;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv) except as may be required as a result of a change in applicable Legal Requirements
or in GAAP, change any of the accounting practices or principles used by it;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvi) adopt a plan of complete or partial liquidation, dissolution, merger,
consolidation, restructuring, recapitalization or other reorganization (other than the
Merger);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvii) maintain insurance in a manner materially inconsistent with past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xviii) enter into any transaction with any of its affiliates (or their respective
family members), other than (A)&nbsp;pursuant to arrangements in effect on the date hereof that
are disclosed in <U>Section&nbsp;5.1(xviii) of the Company Disclosure Schedule</U>, (B)
transactions between the Company and its Subsidiaries in the ordinary course of business
consistent with past practice or (C)&nbsp;the employment of family members at reasonable rates of
pay for temporary summer employment;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xix) increase the compensation payable to Lehman Brothers by the Company or any of its
Subsidiaries (or by the Purchaser of the Surviving Corporation following the Merger) or
otherwise modify or amend any of the material terms of the Company&#146;s agreement with Lehman
Brothers in effect on the date of this Agreement to the extent such terms relate to
compensation, in each case in connection with Lehman Brothers&#146; engagement with respect to
the transactions contemplated hereunder, including the
</DIV>

<P align="center" style="font-size: 10pt">46
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Merger, or pay or agree to pay any other material compensation to Lehman Brothers in
connection with this Agreement and the transactions contemplated hereunder, including the
Merger;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xx) amend, modify or terminate a Material Lease, except for non-substantive amendments
or modifications in the ordinary course of business consistent with past practice, or
effectuate a &#147;plant closing&#148; or &#147;mass layoff,&#148; as those terms are defined in WARN or other
similar Legal Requirement (determined without regard to terminations of employment occurring
on or after the Effective Time);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxi) fail to make in a timely manner any filings with the SEC required under the
Securities Act or the Exchange Act or the respective rules and regulations promulgated
thereunder;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxii) change any of the material terms pursuant to which its products are generally
sold, other than negotiation of individual contracts or purchase orders in the ordinary
course of business consistent with past practice (including customary discount arrangements
with distributors);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxiii) enter into new lines of business (other than in accordance with business plans
of the Company or any of its Subsidiaries that have been disclosed to the Purchaser prior to
the date of this Agreement or discontinuations of products scheduled as of the date of this
Agreement) or cease to engage in any material line of business in which the Company or any
of its Subsidiaries is engaged as of the date of this Agreement; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxiv) authorize any of, or commit or agree to take any of, the foregoing actions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.2 </B><U><B>Preparation of the Proxy Statement; Cooperation on FCPA Matters.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As promptly as reasonably practicable following the execution of this Agreement, the
Company shall prepare and file the Proxy Statement with the SEC. Thereafter, the Company shall use
its reasonable best efforts to have the Proxy Statement cleared by the SEC and to be mailed to its
shareholders as promptly as reasonably practicable. Each of the Purchaser and Merger Sub shall
furnish all information concerning its participation in the Merger transaction and itself and its
Subsidiaries to the Company as may be reasonably requested in connection with the Merger
transaction and the preparation, filing and distribution of the Proxy Statement. The Company shall
cause the Proxy Statement to comply as to form and substance in all material respects with the
applicable requirements of (i)&nbsp;the Exchange Act, including <U>Sections&nbsp;14(A)</U> and <U>14(D)</U>
thereof and the respective regulations promulgated thereunder, (ii)&nbsp;the applicable rules and
regulations of NYSE and (iii)&nbsp;the CGCL. Prior to filing or mailing the Proxy Statement, any
related proxy materials or any amendment or supplement thereto, the Company shall provide the
Purchaser and its advisors with a reasonable opportunity to review and comment on the material to
be filed or mailed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Proxy Statement shall include the Company Board Recommendation, except only as
otherwise permitted by <U>Section&nbsp;5.5(c)</U> of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">47
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company shall notify the Purchaser promptly following receipt of any comments from the
SEC and of any request by the SEC for amendments or supplements to the Proxy Statement and shall
supply the Purchaser with copies of all correspondence with the SEC, as promptly as practicable,
with respect to the Proxy Statement. The Parties shall cooperate in good faith in preparing and
filing the Proxy Statement and any amendments or supplements thereto and in responding to any
requests for additional information and comments from the SEC or the staff thereof. The Company
shall provide the Purchaser and its advisors with a reasonable opportunity to review and comment on
any proposed response (written or oral) to any such comment or request for information and shall
make all changes to such responses as reasonably may be requested by the Purchaser; <I>provided</I>,
<I>however</I>, that the Company shall not be required to make such changes requested by Purchaser solely
to the extent such requests are directly related to (i)&nbsp;the characterization by the Company of any
Acquisition Proposal if the Company believes in good faith that its characterization of any such
Acquisition Proposal is factually accurate with respect to the terms and conditions of such
Acquisition Proposal or (ii)&nbsp;the Company Board Recommendation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If, at any time after the mailing of the definitive Proxy Statement and prior to the
Company Shareholders Meeting, any event should occur that results in the Proxy Statement containing
an untrue statement of a material fact or omitting to state any material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances under which
they are made, not misleading, or that otherwise should be described in an amendment or supplement
to the Proxy Statement, the Company and the Purchaser shall promptly notify each other of the
occurrence of such event and then promptly prepare, file and clear with the SEC such amendment or
supplement and the Company shall, as may be required by the SEC, mail to its shareholders each such
amendment or supplement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company shall promptly (i)&nbsp;notify the Purchaser and Merger Sub following receipt of
any written communication from, or non-written communication with, the U.S. Department of Justice
or the SEC or any other Governmental Authority or their respective staffs that relates to the FCPA
or any other similar Legal Requirement, and (ii)&nbsp;provide the Purchaser with copies of all related
written communication, and a reasonably detailed explanation of all non-written communication. The
Parties shall cooperate in good faith in connection therewith, and in responding to and otherwise
interacting with such Governmental Authorities. The Company shall provide, to the extent
practicable, the Purchaser and its advisors with a reasonable opportunity to review and comment on
any proposed communication (written or oral) to or with any such Governmental Authority, and shall
make all changes to such communications as reasonably may be requested by the Purchaser.
Notwithstanding the foregoing, the Company shall not be obligated to provide the Purchaser with any
communication or other information to the extent expressly prohibited by applicable Legal
Requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.3 </B><U><B>Access to Information.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Throughout the period prior to the earlier of the Effective Time or the Termination Date, the
Company shall, and shall cause each of its Subsidiaries to, afford to the Purchaser and its
officers, employees, counsel, financial advisors and other representatives prompt, reasonable
access during normal business hours to all of the Company&#146;s and its Subsidiaries&#146; properties,
books, contracts, commitments, personnel and records as may be reasonably requested in
</DIV>

<P align="center" style="font-size: 10pt">48
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">connection with the consummation of the Merger, and, during such period, the Company shall,
and shall cause each of its Subsidiaries to, furnish as promptly as practicable to the Purchaser
such information concerning the Company&#146;s and its Subsidiaries businesses, properties, financial
condition, operations and personnel as the Purchaser may from time to time reasonably request;
<I>provided </I>that the Company may restrict the foregoing access to the extent required by applicable
Legal Requirements. Any such investigation by the Purchaser shall not affect the representations
or warranties of the Company contained in this Agreement. The Purchaser shall hold any information
provided under this <U>Section&nbsp;5.3</U> in confidence to the extent required by, and in accordance
with, the provisions of the Confidentiality Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.4 </B><U><B>Company Shareholders&#146; Meeting.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall establish a record date for and cause a meeting of its shareholders to be
duly called and held as soon as reasonably practicable for the purpose of obtaining the Company
Shareholders&#146; Approval (such meeting, the &#147;<U>Company Shareholders&#146; Meeting</U>&#148;). In connection
with the Company Shareholders&#146; Meeting, the Company, acting through its board of directors, will,
subject to <U>Section&nbsp;5.5(c)</U>, (i)&nbsp;recommend the approval of this Agreement and the Merger and
(ii)&nbsp;otherwise comply with all Legal Requirements applicable to such meeting. Without limiting the
generality of the foregoing, but subject to the termination rights of the Parties, the Company&#146;s
obligations pursuant to this <U>Section&nbsp;5.4</U> shall not be affected by the commencement,
proposal, disclosure or communication to the Company or otherwise of any Acquisition Proposal
(including a Superior Proposal).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.5 </B><U><B>No Solicitation.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;From the date of this Agreement until the earlier of the Effective Time or the Termination
Date, the Company shall not, and shall cause its Subsidiaries and the officers, directors,
employees, investment bankers, attorneys, accountants, consultants or other agents, advisors or
representatives (collectively, the &#147;<U>Representatives</U>&#148;) of the Company and each of its
Subsidiaries not to, directly or indirectly:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) solicit, initiate, participate in, or knowingly encourage any Acquisition Proposal,
or engage in any discussions or negotiations with any Person regarding an Acquisition
Proposal;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) disclose any non-public information relating to the Company or any of its
Subsidiaries, or their businesses, assets, liabilities or prospects or afford access to the
properties, books or records of the Company or any of its Subsidiaries to, any Person
regarding an Acquisition Proposal; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) waive or modify any confidentiality, standstill or similar agreement with any
third party;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>provided </I>that, prior to obtaining the Company Shareholders&#146; Approval, the Company may negotiate or
otherwise engage in discussions with, and furnish non-public information relating to the Company or
any of its Subsidiaries, or their businesses, assets, liabilities or prospects or afford access to
the properties, books or records of the Company or any of its Subsidiaries to, any Person (a
&#147;<U>Third Party</U>&#148;) who delivers an unsolicited written <I>bona fide </I>proposal or offer
</DIV>
<P align="center" style="font-size: 10pt">49
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">regarding an Acquisition Proposal if the board of directors of the Company has (i)&nbsp;determined in
good faith (after consulting with a financial advisor of nationally recognized reputation) that
such proposal or offer constitutes or reasonably could be expected to lead to a Superior Proposal;
(ii)&nbsp;provided written notice to the Purchaser of its intent to furnish information or enter into
discussions with such Third Party prior to taking any such action and (iii)&nbsp;obtained from such
Third Party an executed confidentiality agreement and standstill agreement on terms no less
restrictive with respect to such Third Party than those contained in the Confidentiality Agreement
(it being understood that such confidentiality agreement and standstill agreement and any related
agreements shall not include any provision calling for any exclusive right to negotiate with such
Third Party or otherwise having the effect of prohibiting the Company from satisfying its
obligations under this Agreement in full or in part), except that such confidentiality agreement
may permit such Third Party to share confidential information with its financing sources and
Representatives, <I>provided </I>that the Company shall cause the Third Party to agree that such financing
sources and Representatives shall also keep such information confidential in accordance with the
terms of the Confidentiality Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Superior Proposal</U>&#148; means any <I>bona fide</I>, unsolicited written Acquisition Proposal from
a Third Party (i)&nbsp;for more than fifty percent (50%) of the voting power of the Company or fifty
percent (50%) of the consolidated assets of the Company, (ii)&nbsp;which a majority of the entire board
of directors of the Company determines in good faith (after consultation with a financial advisor
of nationally recognized reputation and outside legal counsel, who may be the Company&#146;s regularly
engaged outside legal counsel), taking into account the Person making the Acquisition Proposal and
the likelihood and timing of consummation (including the financial, legal, regulatory and other
aspects of the Acquisition Proposal deemed relevant by the board of directors of the Company in
good faith), would result in a transaction that is superior from a financial point of view to the
Company&#146;s shareholders to the Merger, including any proposed alterations of the terms of this
Agreement proposed by the Purchaser in response to such proposal and (iii)&nbsp;that is not subject to
any material contingency, including any contingency related to financing, unless, in the good faith
judgment of the board of directors of the Company, such contingency is reasonably capable of being
satisfied by such Third Party within a reasonable period of time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company shall, and shall cause its Representatives to, cease immediately and cause to
be terminated all activities, discussions or negotiations, if any, with any Persons conducted prior
to the date hereof with respect to any Acquisition Proposal. The Company shall notify the
Purchaser and Merger Sub (orally and in writing) as promptly as practicable (but in no event later
than one (1)&nbsp;Business Day) after receipt by the Company (or any of its Representatives) of any
proposal or offer for, any Acquisition Proposal, including any amendments or proposed amendments
thereto. Such notice shall identify the material terms and conditions of any such Acquisition
Proposal, including the identity of the Third Party making or considering making such Acquisition
Proposal.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company&#146;s board of directors nor any committee thereof shall (i)&nbsp;withdraw or
modify, or propose publicly to withdraw or modify, in a manner adverse to the Purchaser or Merger
Sub, the Company Board Recommendation or any similar recommendation of any committee of the
Company&#146;s board of directors (any of the foregoing actions being a &#147;<U>Change in the Company
Recommendation</U>&#148;) or (ii)&nbsp;approve or recommend, or agree to approve
</DIV>

<P align="center" style="font-size: 10pt">50
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or recommend or take a position with respect to, or cause or permit the Company or any of its
Subsidiaries to enter into any letter of intent, agreement in principle, acquisition agreement or
other similar arrangement with respect to, any Acquisition Proposal (except for a confidentiality
agreement and standstill agreement with respect to an Acquisition Proposal to the extent permitted
under <U>Section&nbsp;5.5(a)</U>). Notwithstanding the foregoing, (A)&nbsp;if the Company&#146;s board of
directors determines in good faith before the Company Shareholders&#146; Approval is obtained and after
consulting with outside legal counsel (who may be the Company&#146;s regularly engaged outside legal
counsel) and a financial advisor of nationally recognized reputation that the failure to announce a
Change in the Company Recommendation is likely to be inconsistent with the fiduciary duties of the
Company&#146;s board of directors under applicable Legal Requirements, then the Company&#146;s board of
directors may make a Change in the Company Recommendation; and (B)&nbsp;if after considering an
Acquisition Proposal, the Company&#146;s board of directors determines that the Acquisition Proposal
constitutes a Superior Proposal, the Company may enter into a definitive agreement to implement
such Superior Proposal (in the form previously provided to the Purchaser as provided below), but
only (1)&nbsp;after providing written notice to the Purchaser (a &#147;<U>Notice of Superior Proposal</U>&#148;)
advising the Purchaser that the Company&#146;s board of directors has received a Superior Proposal,
specifying the material terms and conditions of such Superior Proposal, identifying the Third Party
making such Superior Proposal and indicating that the Company&#146;s board of directors intends to
effect a Change in the Company Recommendation, accompanied by a copy of the definitive agreement
proposed to be entered into with such Third Party, (2)&nbsp;if the Purchaser does not, within three (3)
Business Days after the Purchaser&#146;s receipt of the Notice of Superior Proposal, make an offer that
is at least as favorable to the Company&#146;s shareholders from a financial point of view (as
determined in good faith by the board of directors of the Company) as such Superior Proposal and
(3)&nbsp;if simultaneously with executing such definitive agreement the Company (x)&nbsp;terminates this
Agreement and (y)&nbsp;pays the Termination Fee to the Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Nothing contained in this <U>Section&nbsp;5.5</U> shall prevent the Company from taking and
disclosing to the shareholders of the Company a position with respect to an Acquisition Proposal by
a Third Party to the extent required by Rule&nbsp;14e-2 and Rule&nbsp;14d-9 under the Exchange Act or making
such disclosure to the Company shareholders if, in the good faith judgment of the Company&#146;s board
of directors (after consulting with its outside legal counsel, who may be the Company&#146;s regularly
engaged outside legal counsel) failure to so disclose would be inconsistent with applicable Legal
Requirements; <I>provided</I>, that in connection therewith neither the Company nor the Company&#146;s board of
directors nor any committee thereof shall, except as specifically permitted herein, make a Change
in the Company Recommendation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.6 </B><U><B>Reasonable Best Efforts; Consents.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, each of the Parties shall, and shall
cause their respective Subsidiaries to, use their reasonable best efforts to take, or cause to be
taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other
Parties in doing, all things necessary, proper or advisable to consummate and make effective, in
the most expeditious manner practicable, the Merger and the other transactions contemplated by this
Agreement, including (i)&nbsp;the obtaining of any necessary consent, authorization, order or approval
of, or any exemption by, any Governmental Authority and/or any other public or private third party
that is required to be obtained by such Party or any of its Subsidiaries in
</DIV>

<P align="center" style="font-size: 10pt">51
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">connection with the Merger and the other transactions contemplated by this Agreement and the
making or obtaining of all necessary filings and registrations with respect thereto, including
filings under the HSR Act, the German Regulation (if required) or any other similar laws, (ii)&nbsp;the
defending of any lawsuits or other legal proceedings before any Governmental Authority seeking to
enjoin, restrain or delay the consummation of the transactions contemplated by this Agreement and
(iii)&nbsp;the execution and delivery of any additional instruments necessary to consummate the
transactions contemplated by, and to fully carry out the purposes of, this Agreement. The Company
and the Purchaser each use their respective reasonable best efforts to comply as promptly as
practicable with any other laws of any Governmental Authority that are applicable to any of the
transactions contemplated hereby and pursuant to which any consent, approval, order or
authorization of, or registration, declaration or filing with, any Governmental Authority or any
other person in connection with such transactions is necessary. The Company and the Purchaser each
shall furnish to the other such necessary information and reasonable assistance as the other may
request in connection with their preparation of any filing, registration or declaration that is
necessary under the HSR Act, the German Regulation (if required) or any other such laws. The
Company and the Purchaser shall keep each other apprised of the status of any communications with,
and any inquiries or requests for additional information from, any Governmental Authority in
respect of any such filing, registration or declaration, and shall use their respective reasonable
best efforts to comply promptly with any such inquiry or request (and, unless precluded by
applicable Legal Requirements, provide copies of any such communications that are in writing).
Neither Party shall independently participate in any meeting, or engage in any substantive
conversation, with any Governmental Authority in respect of any such filings, investigation or
other inquiry without giving the other Party prior notice of the meeting and, to the extent
permitted by such Governmental Authority, the opportunity to attend or participate in such meeting.
The Parties shall use their respective reasonable best efforts to resolve any objections that may
be asserted by any Governmental Authority with respect to the transactions contemplated hereby.
Neither the Purchaser nor Merger Sub will be required by this <U>Section&nbsp;5.6</U> to (i)&nbsp;take any
action, including entering into any consent decree, hold separate orders or other arrangements,
that (x)&nbsp;requires the divestiture of any assets of any of the Purchaser, Merger Sub, the Company or
any of their respective Affiliates, (y)&nbsp;limits the Purchaser&#146;s freedom of action with respect to,
or its ability to retain, the Company and its Subsidiaries or any portion thereof or any of the
Purchaser&#146;s or its Affiliates&#146; other assets or businesses or (z)&nbsp;requires or comprises any other
material financial or other concession or (ii)&nbsp;waive any condition to closing contained in
<U>Article&nbsp;VII</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.7 </B><U><B>Employee Benefits.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Until December&nbsp;31, 2007, the Purchaser shall provide, or shall require the Surviving
Corporation to provide, U.S. and U.K. employees of the Surviving Corporation and its Subsidiaries
with employee benefits (other than equity-based compensation) that are no less favorable in the
aggregate than those provided by the Company and its Subsidiaries to such employees immediately
prior to the Effective Time; <I>provided </I>that, subject to subsection (b)&nbsp;of this <U>Section&nbsp;5.7</U>,
nothing herein shall be construed to mean that the Purchaser or the Surviving Corporation cannot
amend or terminate any particular Benefit Plan, Foreign Plan or any other employee benefit,
compensation or incentive plan, policy or arrangement so long as the requirements of this
<U>Section&nbsp;5.7</U> and applicable Legal Requirements are otherwise satisfied. Nothing in this
subsection (a)&nbsp;shall be construed to cancel or impair existing contractual
</DIV>

<P align="center" style="font-size: 10pt">52
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">obligations of the Company or its Subsidiaries to any employee in effect immediately prior to
the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Without limiting the generality of subsection (a)&nbsp;of this <U>Section&nbsp;5.7</U>, the
Surviving Corporation shall continue to maintain the Diagnostic Products Corporation Retirement
Plan until December&nbsp;31, 2007, and shall provide employees of the Surviving Corporation with levels
of matching contributions, fixed contributions, and variable contributions under such plan that are
no less, when expressed as a percentage of a participant&#146;s compensation, than the levels of each of
such type of contributions made by the Company to its employees under such plan for the plan year
ending on December&nbsp;31, 2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;With respect to any employee benefit plans of the Purchaser in which the employees of the
Surviving Corporation or any of its Subsidiaries participate subsequent to the Effective Time, the
Purchaser shall, or shall cause the Surviving Corporation to (i)&nbsp;waive all limitations as to
pre-existing condition exclusions applicable to such employees to the same extent such exclusions
would have been waived or would otherwise not be excluded under the Benefit Plans or Foreign Plans
in which such employees were participating immediately prior to the Effective Time, (ii)&nbsp;credit all
deductibles and co-pays paid under any of the Company&#146;s or any of its Subsidiaries&#146; health plans
toward deductibles and co-pays under the health plans of the Surviving Corporation or its
Subsidiaries and (iii)&nbsp;recognize all service of the employees of the Company or any of its
Subsidiaries for purposes of eligibility to participate and vesting under any employee benefit
plan, severance policy, vacation, sick, holiday or other paid leave policy, and for purposes of
benefit accrual under any severance policy, vacation, sick, holiday or other paid leave policy, of
the Surviving Corporation or the Purchaser in which such employees may be eligible to participate
after the Effective Time to the same extent taken into account under the corresponding plan or
policy in which such employees participated immediately prior to the Effective Time.
Notwithstanding any terms of the applicable vacation policy of the Purchaser to the contrary, each
of the employees of the Surviving Corporation and its Subsidiaries shall continue to be entitled to
at least that number of days of vacation per year as they had become entitled to under the terms of
the applicable vacation policy of the Company or such Subsidiary of the Company prior to the
Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Nothing in this Agreement shall confer upon any Person any right to continued employment
with the Purchaser or the Surviving Corporation, nor shall anything herein interfere with the right
of the Purchaser or the Surviving Corporation to terminate the employment or services of any Person
at any time following the Effective Time, with or without cause. Except as set forth in
<U>Section&nbsp;5.9</U>, nothing in this Agreement, express or implied, shall confer upon any Employee
(or any of their respective beneficiaries) any rights or remedies under or by reason of this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.8 </B><U><B>Control of Other Party&#146;s Business.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall give the Purchaser or Merger Sub, directly or
indirectly, the right to control or direct the Company&#146;s operations prior to the Effective Time.
Nothing contained in this Agreement shall give the Company, directly or indirectly, the right to
control or direct the Purchaser&#146;s or Merger Sub&#146;s operations prior to the Effective Time. Prior to
</DIV>

<P align="center" style="font-size: 10pt">53
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Effective Time, each of the Parties shall exercise, consistent with and subject to the
terms and conditions of this Agreement, complete control and supervision over their respective
operations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.9 </B><U><B>Directors&#146; and Officers&#146; Indemnification and Insurance.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;For a period of not less than six (6)&nbsp;years following the Effective Time, the Surviving
Corporation shall, and the Purchaser shall cause the Surviving Corporation to, (i)&nbsp;indemnify and
hold harmless all past and present directors, officers and employees (in all of their capacities)
of the Company and its Subsidiaries (such persons, the &#147;<U>Indemnified Parties</U>&#148;) to at least
the same extent such persons are indemnified as of the date hereof by the Company pursuant to the
Company&#146;s or any of its Subsidiaries&#146; articles of incorporation and bylaws or pursuant to
indemnification agreements with such persons, in each case as in existence on the date hereof,
arising out of, relating to or in connection with acts or omissions occurring or alleged to have
occurred prior to the Effective Time (including for acts or omissions occurring in connection with
the approval of this Agreement and the consummation of the transactions contemplated hereby), and
(ii)&nbsp;include and cause to be maintained in effect in the Surviving Corporation&#146;s (or any
successor&#146;s) articles of incorporation and bylaws after the Effective Time, provision regarding the
elimination of liability of directors and officers and the indemnification of the Indemnified
Parties which are, in the aggregate, no less advantageous to the intended beneficiaries than the
corresponding provisions contained in the current articles of incorporation and bylaws of the
Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Surviving Corporation shall, and the Purchaser shall cause the Surviving Corporation
to maintain for a period of at least six (6)&nbsp;years after the Effective Time coverage under the
Company&#146;s directors&#146; and officers&#146; liability insurance policies as in effect on the date hereof for
acts or omissions occurring prior to the Effective Time (&#147;<U>D&#038;O Insurance</U>&#148;); <I>provided </I>that
(A)&nbsp;the Purchaser may substitute therefor policies with a reputable insurer of comparable credit
quality of substantially similar coverage and amounts containing terms no less advantageous
individually or in the aggregate to the Indemnified Parties, (B)&nbsp;if the existing D&#038;O Insurance
expires or is canceled during such period, the Purchaser and the Surviving Corporation will use
their reasonable best efforts to obtain substantially similar D&#038;O Insurance from a reputable
insurer of comparable credit quality, (C)&nbsp;in no event shall the Purchaser or the Surviving
Corporation be required to expend more than 250% of the last annual premiums paid by the Company
immediately prior to the Effective Time (which the Company represents and warrants to be the amount
set forth in <U>Section&nbsp;5.9(b) of the Company Disclosure Schedule</U>) (the &#147;<U>Maximum Premium
Amount</U>&#148;) to maintain or procure D&#038;O Insurance pursuant to this <U>Section&nbsp;5.9</U> and (D)&nbsp;if
the annual premiums of such D&#038;O Insurance would exceed the Maximum Premium Amount, the Purchaser or
the Surviving Corporation shall obtain a policy with the greatest coverage reasonably available for
a cost not exceeding the Maximum Premium Amount. In lieu of the foregoing, the Purchaser may, or
may cause the Surviving Corporation to, purchase six-(6) year tail coverage covering acts or
omissions prior to the Effective Time on terms not materially less favorable to any director,
officer or employee to the existing policy of the Company as in effect on the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The provisions of this <U>Section&nbsp;5.9</U> shall survive consummation of the Merger and
expressly are intended to benefit each of the Indemnified Parties. The rights of each
</DIV>

<P align="center" style="font-size: 10pt">54
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indemnified Party hereunder shall be in addition to, and not in limitation of, any other
rights such Indemnified Party may have under any other indemnification arrangement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If the Purchaser or the Surviving Corporation or any of their respective successors or
assigns (i)&nbsp;consolidates with or merges into any other person and shall not be the continuing or
surviving corporation or entity in such consolidation or merger or (ii)&nbsp;transfers all or
substantially all of its properties and assets to any Person, then and in either case, proper
provision shall be made so that the successors and assigns of the Purchaser or the Surviving
Corporation shall assume the obligations in this <U>Section&nbsp;5.9</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Purchaser and the Surviving Corporation shall pay all reasonable costs and expenses,
including reasonable attorneys&#146; fees, that may be incurred by any Indemnified Party in successfully
enforcing the indemnity and other obligations set forth in this <U>Section&nbsp;5.9</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.10 </B><U><B>Public Statement and Press Releases.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the Parties agrees that it shall not, without the prior written consent of the other
Parties, make any press release or other public statement (other than the Proxy Statement)
concerning this Agreement, the Shareholder Agreement or the transactions contemplated hereby or
thereby, including the Merger; <I>provided</I>, <I>however</I>, that (i)&nbsp;the Parties shall mutually agree upon
their respective initial press releases regarding the execution of this Agreement and the
transactions contemplated hereby, (ii)&nbsp;nothing in this <U>Section&nbsp;5.10</U> shall be deemed to
prohibit any Party or any of its affiliates from making any disclosure that is consistent in all
material respects with the press releases issued by either Party pursuant to clause (i)&nbsp;and (iii)
nothing in this <U>Section&nbsp;5.10</U> shall be deemed to prohibit any Party or any of its affiliates
from making any disclosure that its counsel deems necessary in order to fulfill such Party&#146;s or
affiliate&#146;s disclosure obligations imposed by Legal Requirements or the rules of any national
securities exchange or automated quotation system, so long as the disclosing Party (on behalf of
itself or its affiliates, as applicable) consults with the other Parties prior to such disclosure.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.11 </B><U><B>Notice Obligations.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the Effective Time, each of the Company and the Purchaser shall promptly advise the
other of any change or event (i)&nbsp;having or reasonably likely to have a Material Adverse Effect on
it (in the case of the Company) or a material adverse effect on its ability to consummate the
transactions contemplated hereunder (in the case of the Purchaser), (ii)&nbsp;that it believes would or
would be reasonably likely to result in a failure of any of the conditions set forth in <U>Article
VI</U>, <U>VII</U> or <U>VIII</U>, as applicable, to be satisfied; <I>provided</I>, <I>however</I>, that a
failure to comply with this <U>Section&nbsp;5.11</U> shall not constitute a breach of this Agreement or
the failure of any condition set forth in <U>Article&nbsp;VII</U> or <U>VIII</U>, as applicable, to be
satisfied unless the underlying Material Adverse Effect or material breach would independently
result in the failure of a condition set forth in <U>Article&nbsp;VII</U> or <U>VIII</U>, as
applicable, to be satisfied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;5.12 </B><U><B>Shareholder Claims.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall advise the Purchaser promptly of the assertion or purported assertion of any
claims by or on behalf of shareholders of the Company against the Company or any of its
</DIV>

<P align="center" style="font-size: 10pt">55
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">officers or directors; and shall give the Purchaser a reasonable opportunity to consult in the
response to and defense of any such shareholder claims. Subject to <U>Section&nbsp;5.5</U>, the
Company shall use its reasonable best efforts to defend any Actions instituted by any shareholder
to restrain or prohibit or otherwise oppose the Merger, this Agreement, the Shareholder Agreement
or the transactions contemplated hereby or thereby. The Purchaser shall cooperate with the Company
in its efforts to defend such Actions, <I>provided </I>that any request from the Company for such
cooperation is reasonable.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VI</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS TO EACH PARTY&#146;S OBLIGATIONS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The respective obligations of each Party to this Agreement to complete the transactions
provided for herein are subject to the fulfillment (or waiver by the Parties) at or prior to the
Effective Time of the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;6.1 </B><U><B>Company Shareholders&#146; Approval.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company Shareholders&#146; Approval shall have been obtained in accordance with applicable
Legal Requirements, the articles of incorporation and bylaws of the Company and the provisions of
this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;6.2 </B><U><B>Legal Prohibition.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Legal Prohibition shall have been enacted and be in effect; <I>provided, however</I>, that each of
the Parties shall use their reasonable best efforts to prevent any such Legal Prohibition and to
cause any such Legal Prohibition to be vacated or otherwise rendered of no effect, and to take such
other actions as are consistent therewith to the extent necessary to remove the Legal Prohibition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;6.3 </B><U><B>Receipt of Government Consents.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All consents, approvals, authorizations, qualifications and orders of any Governmental
Authority set forth in <U>Section&nbsp;6.3 of the Company Disclosure Schedule</U>, in form reasonably
satisfactory to the Parties, shall have been obtained and shall be in full force and effect as of
the Closing and any waiting period (and any extension thereof) under the HSR Act shall have expired
and, if required, one of the Parties shall have received a notification from the German Federal
Cartel Office (Bundeskartellamt) that the requirements for a prohibition of the Merger are not met
or the applicable time periods for the issue of a prohibition order by the German Federal Cartel
Office shall have expired under the German Regulation.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS TO THE PURCHASER&#146;S AND MERGER SUB&#146;S OBLIGATIONS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The obligations of the Purchaser and Merger Sub to complete the transactions provided for in
this Agreement are subject to the fulfillment (or waiver by the Purchaser or Merger Sub) at or
prior to the Effective Time of the following conditions:
</DIV>

<P align="center" style="font-size: 10pt">56
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;7.1 </B><U><B>Receipt of Third Party Consents.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All consents, approvals and authorizations listed in <U>Section&nbsp;7.1 of the Company Disclosure
Schedule</U> shall have been obtained and evidence thereof, in form reasonably satisfactory to the
Purchaser, shall have been delivered to the Purchaser and shall be in full force and effect as of
the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;7.2 </B><U><B>Performance by Company.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have performed in all material respects all of its agreements and covenants
contained in this Agreement required to be performed by it at or prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;7.3 </B><U><B>Truth of Representations and Warranties.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the representations and warranties of the Company contained in this Agreement (i)&nbsp;if
specifically qualified by materiality, Material Adverse Effect or other similar terms shall be true
and correct as so qualified and (ii)&nbsp;if not qualified by materiality, Material Adverse Effect or
other similar terms shall be true and correct in all material respects, in each such case on and as
of the date hereof and as of the Closing Date, with the same effect as if then made (except where
any such representation or warranty is as of a specific earlier date, in which event it shall
remain true and correct (as qualified) as of such earlier date), except with respect to both
clauses (i)&nbsp;and (ii)&nbsp;for any failure to be so true and correct (without giving effect to any
limitation as to materiality, Material Adverse Effect or other similar terms set forth therein)
that has not had and reasonably would not be expected to have, individually or in the aggregate, a
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;7.4 </B><U><B>Company&#146;s Closing Certificate.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have delivered to the Purchaser at Closing an officer&#146;s certificate of the
Company, duly executed by the Chief Executive Officer, solely in such capacity on behalf of the
Company, certifying (i)&nbsp;as to the incumbency and signatures of the officers of the Company who
executed this Agreement, (ii)&nbsp;as to the adoption of resolutions of the board of directors of the
Company being correct, complete and in full force and effect on the Closing Date (though not
necessarily dated as of the Closing Date), authorizing (A)&nbsp;the execution and delivery of this
Agreement and (B)&nbsp;the performance of the obligations of the Company hereunder, (iii)&nbsp;as to the
Company&#146;s bylaws and all amendments thereto being correct, complete and in full force and effect on
the Closing Date and (iv)&nbsp;that the conditions to the Purchaser&#146;s and Merger Sub&#146;s obligations to
consummate the transactions contemplated by this Agreement set forth in <U>Sections&nbsp;7.2</U> and
<U>7.3</U> have been satisfied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;7.5 </B><U><B>Material Adverse Effect.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since the date of this Agreement there shall not have been or occurred any Material Adverse
Effect, or any event, change, effect or circumstance that, individually or in the aggregate,
reasonably would be expected to have a Material Adverse Effect. In determining whether there has
been a Material Adverse Effect, any event, change, effect or circumstance will
</DIV>

<P align="center" style="font-size: 10pt">57
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be considered individually and in the aggregate with all other events, changes, effects or
circumstances.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;7.6 </B><U><B>FIRPTA Certificate.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have delivered within thirty (30)&nbsp;days prior to the Closing Date a
certificate in the form contemplated by Section&nbsp;897 of the Code and the regulations thereunder,
signed by the Company, to the effect that the Company is not and has not been within five (5)&nbsp;years
of the date of the certificate a &#147;United States real property holding corporation&#148; within the
meaning of Section&nbsp;897 of the Code.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VIII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS TO COMPANY&#146;S OBLIGATIONS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The obligations of the Company to complete the transactions provided for in this Agreement are
subject to the fulfillment (or waiver by the Company) at or prior to the Effective Time of the
following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;8.1 </B><U><B>Performance by the Purchaser and Merger Sub.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Purchaser and Merger Sub shall have performed in all material respects all of their
respective agreements and covenants contained in this Agreement required to be performed by such
Party at or prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;8.2 </B><U><B>Truth of Representations and Warranties.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the representations and warranties of the Purchaser and Merger Sub contained in this
Agreement (i)&nbsp;if specifically qualified by materiality, material adverse effect or other similar
terms shall be true and complete as so qualified and (ii)&nbsp;if not qualified by materiality, material
adverse effect or similar term shall be true and correct in all material respects, in each such
case on and as of the date hereof and as of the Closing Date, with the same effect as if then made
(except where any such representation or warranty is as of a specific earlier date, in which event
it shall remain true and correct (as qualified) as of such earlier date), except with respect to
both clauses (i)&nbsp;and (ii)&nbsp;for any failure to be so true and correct (without giving effect to any
limitation as to materiality, material adverse effect or other similar terms set forth therein)
that has not had and reasonably would not be expected to have, individually or in the aggregate, a
material adverse effect on the Purchaser&#146;s or Merger Sub&#146;s ability to consummate the transactions
contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;8.3 </B><U><B>Purchaser&#146;s Closing Certificate.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Purchaser shall deliver to the Company at Closing an officer&#146;s certificate of the
Purchaser, solely in such capacity on the behalf of the Purchaser, certifying (i)&nbsp;as to the
incumbency and signatures of the officers of the Purchaser and Merger Sub who execute this
Agreement, (ii)&nbsp;as to the adoption of resolutions of the board of directors of the Purchaser and
Merger Sub being correct, complete and in full force and effect on the Closing Date (though not
necessarily dated as of the Closing Date), authorizing (A)&nbsp;the execution and delivery of this
</DIV>

<P align="center" style="font-size: 10pt">58
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Agreement and (B)&nbsp;the performance of the obligations of the Purchaser and Merger Sub
hereunder, (iii)&nbsp;as to the Purchaser&#146;s and Merger Sub&#146;s bylaws and all amendments thereto being
correct, complete and in full force and effect on the Closing Date and (iv)&nbsp;to such officer&#146;s
knowledge, that the conditions to the Company&#146;s obligations to consummate the transactions
contemplated by this Agreement set forth in <U>Sections&nbsp;8.1</U> and <U>8.2</U> with respect to
the Purchaser and Merger Sub have been satisfied.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IX</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>TERMINATION</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;9.1 </B><U><B>Termination.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be terminated and the Merger may be abandoned at any time prior to the
Effective Time (any such date, the &#147;<U>Termination Date</U>&#148;):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;by the mutual written agreement of the Company and the Purchaser;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;by either the Company or the Purchaser upon written notice to the other Party:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) if the Merger has not been consummated on or before November&nbsp;1, 2006 (such date, as
it may be extended as set forth below, the &#147;<U>End Date</U>&#148;); <I>provided </I>that the right to
terminate this Agreement pursuant to this <U>Section&nbsp;9.1(b)(i)</U> shall not be available
to a Party whose breach of any provision of this Agreement results in the failure of the
Merger to be consummated by the End Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) after the date of this Agreement, if any Governmental Authority shall have
enacted, issued, promulgated, enforced or entered any statute, rule, regulation, executive
order, decree, judgment, injunction or other order, in any case that is in effect, final and
non-appealable and that prevents or prohibits consummation of the Merger (a &#147;<U>Legal
Prohibition</U>&#148;); or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) if the Company Shareholders&#146; Approval shall not have been obtained following a
vote at the Company Shareholders&#146; Meeting (or any adjournment or postponement thereof);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by the Purchaser upon written notice to the Company:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) at any time after a Change in the Company Recommendation or if the board of
directors of the Company (or any committee thereof) shall have (x)&nbsp;approved or recommended
or announced a neutral position with respect to any Acquisition Proposal or (y)&nbsp;failed to
reaffirm its recommendation of this Agreement and the Merger within five (5)&nbsp;Business Days
of being requested by the Purchaser to do so, or (z)&nbsp;resolved to do any of the foregoing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) (A)&nbsp;if any of the Company&#146;s representations and warranties shall have been
inaccurate as of the date of this Agreement, such that the condition set forth in
</DIV>

<P align="center" style="font-size: 10pt">59
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%"><U>Section&nbsp;7.3</U> would not be satisfied, or (B)&nbsp;if any of the Company&#146;s
representations and warranties become inaccurate as of a date subsequent to the date of this
Agreement (as if made on such subsequent date), such that the condition set forth in
<U>Section&nbsp;7.3</U> would not be satisfied, or (C)&nbsp;if any of the Company&#146;s covenants
contained in this Agreement shall have been breached, such that the condition set forth in
<U>Section&nbsp;7.2</U> would not be satisfied; <I>provided </I>that no such inaccuracy or breach under
the foregoing clauses shall give rise to a right to terminate, unless such inaccuracy or
breach cannot be or is not cured within thirty (30)&nbsp;days of notice of such inaccuracy or
breach from the Purchaser (or, if sooner, the date prior to the End Date);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) by the Company upon written notice to the Purchaser:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) in accordance with the terms and subject to the conditions of <U>Section
5.5(c)</U>; <I>provided </I>that such termination under this clause (d)(i) shall not be effective
until the Company has tendered payment of the fee required pursuant to <U>Section
9.3(d)</U>; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) (A)&nbsp;if any of the Purchaser&#146;s or Merger Sub&#146;s representations and warranties shall
have been inaccurate as of the date of this Agreement, such that the condition set forth in
<U>Section&nbsp;8.2</U> would not be satisfied, or (B)&nbsp;if any of the Purchaser&#146;s and Merger
Sub&#146;s representations and warranties become inaccurate as of a date subsequent to the date
of this Agreement (as if made on such subsequent date), such that the condition set forth in
<U>Section&nbsp;8.2</U> would not be satisfied, or (C)&nbsp;if any of the Purchaser&#146;s and Merger
Sub&#146;s covenants contained in this Agreement shall have been breached, such that the
condition set forth in <U>Section&nbsp;8.1</U> would not be satisfied; <I>provided </I>that no such
inaccuracy or breach under the foregoing clauses shall give rise to a right to terminate,
unless such inaccuracy or breach cannot be or is not cured within thirty (30)&nbsp;days of notice
of such inaccuracy or breach from the Company (or, if sooner, the date prior to the End
Date).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;9.2 </B><U><B>Effect of Termination.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated pursuant to <U>Section&nbsp;9.1</U>, this Agreement shall become
void and of no effect without liability of any Party (or any shareholder, director, officer,
employee, agent, consultant or representative of such Party) to the other Parties hereto, except
that (i)&nbsp;the agreements contained in <U>Sections&nbsp;9.2</U> and <U>9.3</U> and <U>Article&nbsp;X</U> of
this Agreement and in the Confidentiality Agreement shall survive the termination hereof and (ii)
no such termination shall relieve any Party of any liability for damages resulting from any willful
breach by such Party of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;9.3 </B><U><B>Fees and Expenses.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as otherwise provided in this <U>Section&nbsp;9.3</U>, all costs and expenses incurred
in connection with this Agreement shall be paid by the Party incurring such cost or expense whether
or not the Merger is consummated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Under the circumstances and at the times specified in this <U>Section&nbsp;9.3</U>, the
Company shall pay to the Purchaser a termination fee of $44,000,000 in cash (the &#147;<U>Termination</U>
</DIV>

<P align="center" style="font-size: 10pt">60
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Fee</U>&#148;). The amount of the Termination Fee may, in certain circumstances, be reduced as
provided in <U>Section&nbsp;9.3(g)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If (A)&nbsp;this Agreement is terminated pursuant to <U>Section&nbsp;9.1(b)(i)</U> &#091;End Date&#093;,<U>
9.1(b)(iii)</U> &#091;No Vote&#093;, <U>9.1(c)(i)</U> after a Change in Recommendation, or
<U>9.1(c)(ii)(C)</U> &#091;Company Breach&#093; by reason of a breach of <U>Sections&nbsp;5.2(a)</U> or<U>
(b)</U>, <U>5.4</U> or<U> 5.5</U>, (B)&nbsp;prior to such termination, an Acquisition Proposal is made
by any Third Party and (C)&nbsp;within twelve (12)&nbsp;months after such termination, either (1)&nbsp;the Company
or any of its Subsidiaries enters into any letter of intent, agreement in principle, acquisition
agreement or other similar arrangement with any Third Party with respect to, or consummates, an
Acquisition Proposal or (2)&nbsp;if neither the Company nor any of its Subsidiaries has entered into an
agreement or other arrangement contemplated in clause (C)(1) and any Third Party commences a tender
or exchange offer that, if consummated, would result in the acquisition by such Third Party, or any
affiliate thereof, making the tender or exchange offer of fifty percent (50%) or more of the
Company Common Stock, then in either case the Company shall pay the Termination Fee to the
Purchaser at the times provided in <U>Section&nbsp;9.3(e)</U>. The Parties agree that if a Termination
Fee is paid by the Company to the Purchaser pursuant to the terms of this <U>Section&nbsp;9.3(c)</U>,
then such Termination Fee (together with any expense reimbursement paid pursuant to <U>Section
9.3(g)</U>) shall be the Purchaser&#146;s and Merger Sub&#146;s exclusive remedy for the matters covered by
this <U>Section&nbsp;9.3(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If this Agreement is terminated by the Company pursuant to <U>Section&nbsp;9.1(d)(i)</U>
&#091;Superior Proposal&#093;, then the Company shall pay the Termination Fee to the Purchaser simultaneously
with such termination as provided in <U>Section&nbsp;9.1(d)(i)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If the Termination Fee becomes payable pursuant to <U>Section&nbsp;9.3(c)</U>, then the
Company shall pay the Termination Fee (i)&nbsp;within one (1)&nbsp;Business Day after the consummation of the
transaction pursuant to the agreement or other arrangement, as the case may be and as contemplated
by <U>Section&nbsp;9.3(c)(C)(1)</U>, or (ii)&nbsp;within one (1)&nbsp;Business Day after the closing of the
tender or exchange offer contemplated by <U>Section&nbsp;9.3(c)(C)(2)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Any payment of the Termination Fee shall be made by wire transfer of immediately available
funds to an account specified by the Purchaser.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;If this Agreement is terminated pursuant to <U>Section&nbsp;9.1(b)(iii)</U> &#091;No Vote&#093;,
<U>9.1(c)(i)</U> after a Change in Recommendation, or <U>9.1(c)(ii)(C)</U> &#091;Company Breach&#093; by
reason of a breach of <U>Sections&nbsp;5.2(a) or (b), 5.4 or 5.5</U>, and if, prior to such
termination, an Acquisition Proposal is made by any Third Party, then the Company shall, promptly
after receipt from the Purchaser of a reasonably-detailed invoice therefor, reimburse the Purchaser
for all reasonable out-of-pocket expenses (including all reasonable fees and expenses of counsel,
accountants, auditors, investment bankers, experts and other advisors) incurred by it or on its
behalf in connection with or related to this Agreement, the Shareholder Agreement and all of the
respective transactions contemplated thereby, including the Merger, up to a maximum aggregate
amount not to exceed $7,000,000. Any Termination Fee paid after a payment pursuant to this
paragraph (g)&nbsp;shall be reduced by the amount of the payment made pursuant to this paragraph (g).
</DIV>

<P align="center" style="font-size: 10pt">61
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The Company acknowledges that the agreements contained in this <U>Section&nbsp;9.3</U> are an
integral part of the transactions contemplated in this Agreement, and that, without these
agreements, the Purchaser would not have entered into this Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE X</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>MISCELLANEOUS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.1 </B><U><B>Amendments, Waivers.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may only be amended pursuant to a written agreement executed by all the
Parties, and no waiver of compliance with any provision or condition of this Agreement and no
consent provided for in this Agreement shall be effective unless evidenced by a written instrument
executed by each Party against whom such waiver or consent is to be effective; <I>provided</I>, <I>however</I>,
that after obtaining the Company Shareholder Approval, no amendment or waiver of this Agreement
shall be effective that by applicable Legal Requirement or applicable rule and regulation of any
relevant stock exchange or automated quotation system requires further approval of the shareholders
of the Company unless the required approval is obtained. No waiver of any term or provision of
this Agreement shall be construed as a further or continuing waiver of such term or provision or
any other term or provision.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.2 </B><U><B>Entire Agreement.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement, the Confidentiality Agreement, the Shareholder Agreement and the Disclosure
Schedules to this Agreement constitute the entire agreement of all the Parties and supersedes any
and all prior and contemporaneous agreements, memoranda, arrangements and understandings, both
written and oral, among the Parties, or between any two of them, with respect to the subject matter
hereof. No representation, warranty, promise, inducement or statement of intention has been made
by any Party that is not contained in this Agreement or Disclosure Schedules to this Agreement and
no Party shall be bound by, or be liable for, any alleged representation, promise, inducement or
statement of intention not contained herein or therein. For the avoidance of doubt, all Disclosure
Schedules to this Agreement are expressly made a part of, and incorporated by reference into, this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.3 </B><U><B>Binding Effect; Assignment.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be binding upon and inure to the benefit of and be enforceable by the
Parties and their respective successors and permitted assigns. No Party to this Agreement may
assign its rights or delegate its obligations under this Agreement, whether by operation of law or
otherwise, to any other Person without the express prior written consent of the other Parties
hereto, and any such assignment or transfer made without the prior written consent of the other
Parties hereto shall be null and void; <I>provided </I>that Merger Sub may assign any or all of its rights
and obligations hereunder to the Purchaser or any wholly-owned domestic Subsidiary of the
Purchaser.
</DIV>

<P align="center" style="font-size: 10pt">62
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.4 </B><U><B>Headings; Certain Construction Rules.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Article, Section and paragraph headings and the table of contents contained in this
Agreement are for reference purposes only and do not form a part of this Agreement and do not in
any way modify, interpret or construe the intentions of the Parties. As used in this Agreement,
unless otherwise provided to the contrary, (A)&nbsp;all references to days or months shall be deemed
references to calendar days or months and (B)&nbsp;any reference to a &#147;Section&#148; or &#147;Article&#148; shall be
deemed to refer to a Section or article of this Agreement. The words &#147;hereof,&#148; &#147;herein&#148; and
&#147;hereunder&#148; and words of similar import referring to this Agreement refer to this Agreement as a
whole and not to any particular provision of this Agreement. Whenever the words &#147;include,&#148;
&#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the
words &#147;without limitation.&#148; Unless otherwise specifically provided for herein, the term &#147;or&#148; shall
not be deemed to be exclusive. The Parties have participated jointly in negotiating and drafting
this Agreement. If an ambiguity or a question of intent or interpretation arises, this Agreement
shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof
shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this
Agreement. All terms defined in this Agreement have their defined meanings when used in any
certificate or other document made or delivered pursuant hereto, unless otherwise defined therein.
If any action is to be taken by any Party hereto pursuant to this Agreement on a day that is not a
Business Day, such action shall be taken on the next Business Day following such day. &#147;Reasonable
best efforts&#148; or similar terms shall not require the waiver of any rights under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.5 </B><U><B>Notices.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All notices, requests, claims, demands and other communications hereunder shall be in writing
and shall be deemed to have been duly given to a Party if delivered in person or sent by overnight
delivery (providing proof of delivery) to the Parties at the following addresses (or at such other
address for a Party as shall be specified by like notice) on the date of delivery, or if by
facsimile, upon confirmation of receipt:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="41%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">If to the Purchaser or Merger Sub:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Siemens Medical Solutions USA, Inc.<BR>
51 Valley Stream Parkway<BR>
Malvern, Pennsylvania 19355<BR>
Facsimile No: (610)&nbsp;448-1710<BR>
Attention: &nbsp;Secretary</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">with a copy to:</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Siemens Corporation<BR>
153 East 53rd Street, 56th Floor<BR>
New York, New York 10022<BR>
Facsimile No: (212)&nbsp;258-4490</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Attention: &nbsp;General Counsel</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">With a copy (which shall not constitute notice) to:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Clifford Chance US LLP<BR>
31 West 52nd Street<BR></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">63
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="41%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">New York, NY 10019</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John A. Healy</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karl A. Roessner</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Telecopier:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">212-878-8375</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">If to the Company:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Diagnostics Products Corporation<BR>
5210 Pacific Concourse Drive<BR>
Los Angeles, California 90045</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Ziering</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Telecopier:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(310) 645-9999</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">With a copy (which shall not constitute notice) to:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">O&#146;Melveny &#038; Myers LLP<BR>
400 South Hope Street<BR>
Los Angeles, CA 90071</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">C. James Levin</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Telecopier:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">213-430-6407</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.6 </B><U><B>Governing Law.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be governed by and construed and enforced in accordance with the laws of
the State of California, without giving effect to the conflicts of law provisions thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.7 </B><U><B>Further Actions.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At any time and from time to time after the Closing, each Party hereto shall, at its own
expense (except as otherwise provided herein), take such actions and execute and deliver such
documents as may be reasonably necessary to effectuate the purposes of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.8 </B><U><B>Gender, Tense, Etc.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where the context or construction requires, all words applied in the plural shall be deemed to
have been used in the singular, and vice versa; the masculine shall include the feminine and
neuter, and vice versa; and the present tense shall include the past and future tense, and vice
versa.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.9 </B><U><B>Severability.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any provision or any part of any provision of this Agreement shall be void or unenforceable
for any reason whatsoever, then such provision shall be stricken and of no force and effect.
Unless such stricken provision goes to the essence of the consideration bargained for by a Party,
however, the remaining provisions of this Agreement shall continue in full force and effect and, to
the extent required, shall be modified to preserve their validity. Upon such determination that
any term or other provision or any part of any provision is void or unenforceable, the Parties
shall negotiate in good faith to modify this Agreement so as to effect
</DIV>

<P align="center" style="font-size: 10pt">64
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the original intent of the Parties as closely as possible in an acceptable manner to the end
that the transactions contemplated hereby are fulfilled to the fullest extent possible.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.10 </B><U><B>No Third Party Rights.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than as set forth in <U>Section&nbsp;5.9</U> (which is intended to benefit the Indemnified
Parties), nothing in this Agreement, whether express or implied, is intended to or shall confer any
rights, benefits or remedies under or by reason of this Agreement on any Persons other than the
Parties and their respective successors and permitted assigns, nor is anything in this Agreement
intended to relieve or discharge the obligation or liability of any third party Persons to any
Party, nor shall any provisions give any third party Persons any right of subrogation over or
action against any Party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.11 </B><U><B>Survival of Representations and Warranties and Agreements.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the representations, warranties, covenants and other agreements in this Agreement or
in any instrument delivered pursuant to this Agreement, or any claim with respect thereto, shall
survive the Effective Time, except for those covenants, agreements and other provisions contained
herein that by their terms apply or are to be performed in whole or in part after the Effective
Time, including <U>Sections&nbsp;5.7</U> and <U>5.9</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.12 </B><U><B>Counterparts.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To facilitate execution, this Agreement may be executed in any number of counterparts
(including by facsimile transmission), each of which shall be deemed to be an original, but all of
which together shall constitute one binding agreement on the Parties, notwithstanding that not all
Parties are signatories to the same counterpart.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Section&nbsp;10.13 </B><U><B>Waiver of Jury Trial.</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Party waives any right to a trial by jury in any Action to enforce or defend any right
under this Agreement or any amendment, instrument, document or agreement delivered, or which in the
future may be delivered, in connection with this Agreement and agrees that any Action shall be
tried before a court and not before a jury.
</DIV>

<P align="center" style="font-size: 10pt">65
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above
written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="60%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="36%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SIEMENS MEDICAL SOLUTIONS USA, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/&nbsp;Prof. Dr.&nbsp;Erich R. Reinhardt</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prof. Dr.&nbsp;Erich R. Reinhardt</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chairman</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/&nbsp;Georg Obermeyer</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Georg Obermeyer</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">DRESDEN ACQUISITION CORPORATION</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/&nbsp;Georg Obermeyer</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Georg Obermeyer</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasurer</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/&nbsp;Kenneth R. Meyers</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kenneth R. Meyers</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">DIAGNOSTIC PRODUCTS CORPORATION</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/&nbsp;Michael Ziering</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Michael Ziering</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
